IIS: NDC Lookup Crosswalk

Related Pages

Email Updates‎

Subscribe to receive email updates about this page.
Get email updates

This webpage is designed as a lookup table where the Unit of Use and Unit of Sale NDC are mapped to each other. A few vaccines are packaged with two component vaccines. Each component vaccine of a multiple component vaccine will have a unique NDC which also differs from the NDC of the unit of sale. Pentacel is an example. This means that there will be two rows linking the unit of use to unit of sale.

Global Trade Identification Numbers (GTINs) are provided as a proxy indicator that the vaccine is 2D barcoded. Note that we have recently learned that some of the GTINs in this table are inaccurate due to variations in the GTIN formats used by manufacturers. Specifically, some vaccine manufacturers are populating the first digit of the GTIN as a packaging level Indicator. Users are advised to use these GTIN values with caution until CDC can verify accuracy with the vaccine manufacturers.

A new expanded version of the NDC Lookup Crosswalk table is now available for download only. This new NDC Consolidated Crosswalk file provides additional field and code details and adds CPT codes associated to NDC Units of Use

Sort Table by Column: Simply click on the column heading to sort the table accordingly.

The columns are defined after the table.

Sale
NDC11		Sale Proprietary
Name		Sale LabelerStart DateEnd DateSale GTINSale
Last Update		Use
NDC11		No Use
NDC		Use
GTIN		Use
Last Update		CVX CodeCVX
Description		MVX Code
00005-0100-02 TrumenbaWyeth Pharmaceutical Division of Wyeth Holdings LLC11/5/201400300050100027 11/22/201900005-0100-01 False 00300050100010 2/1/2023162 meningococcal B, recombinantPFR
00005-0100-05 TrumenbaWyeth Pharmaceutical Division of Wyeth Holdings LLC11/5/201400300050100058 11/22/201900005-0100-01 False 00300050100010 2/1/2023162 meningococcal B, recombinantPFR
00005-0100-10 TrumenbaWyeth Pharmaceutical Division of Wyeth Holdings LLC11/5/201400300050100102 11/22/201900005-0100-01 False 00300050100010 2/1/2023162 meningococcal B, recombinantPFR
00005-1970-50 PrevnarWyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc.3/1/200012/31/2011 5/30/201800005-1970-49 False 5/30/2018100 pneumococcal conjugate PCV 7WAL
00005-1971-02 PREVNAR 13Wyeth Pharmaceutical Division of Wyeth Holdings LLC3/12/201000300051971022 8/6/202400005-1971-01 False 00300051971015 8/6/2024133 Pneumococcal conjugate PCV 13PFR
00005-1971-04 PREVNAR 13Wyeth Pharmaceutical Division of Wyeth Holdings LLC, a subsidiary of Pfizer Inc.3/12/20107/29/2016 2/3/202300005-1971-01 False 00300051971015 8/6/2024133 Pneumococcal conjugate PCV 13PFR
00005-1971-05 PREVNAR 13Wyeth Pharmaceutical Division of Wyeth Holdings LLC3/12/201000300051971053 8/6/202400005-1971-01 False 00300051971015 8/6/2024133 Pneumococcal conjugate PCV 13PFR
00005-2000-02 Prevnar 20Wyeth Pharmaceutical Division of Wyeth Holdings LLC8/10/202100300052000028 2/13/202400005-2000-01 False 10300052000018 2/13/2024216 Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PFPFR
00005-2000-10 Prevnar 20Wyeth Pharmaceutical Division of Wyeth Holdings LLC8/10/202100300052000103 2/13/202400005-2000-01 False 10300052000018 2/13/2024216 Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PFPFR
00006-4045-00 GARDASILMerck Sharp & Dohme LLC6/8/2006 7/5/202200006-4045-01 False 00300064045017 2/1/202362 HPV, quadrivalentMSD
00006-4045-41 GARDASILMerck Sharp & Dohme LLC6/8/2006 7/5/202200006-4045-01 False 00300064045017 2/1/202362 HPV, quadrivalentMSD
00006-4047-20 RotaTeqMerck Sharp & Dohme LLC2/3/200600300064047202 5/17/202200006-4047-02 False 2/1/2023116 rotavirus, pentavalentMSD
00006-4047-20 RotaTeqMerck Sharp & Dohme LLC2/3/200600300064047202 5/17/202200006-4047-01 False 00300064047011 2/1/2023116 rotavirus, pentavalentMSD
00006-4047-41 RotaTeqMerck Sharp & Dohme LLC2/3/200600300064047417 5/17/202200006-4047-02 False 2/1/2023116 rotavirus, pentavalentMSD
00006-4047-41 RotaTeqMerck Sharp & Dohme LLC2/3/200600300064047417 5/17/202200006-4047-01 False 00300064047011 2/1/2023116 rotavirus, pentavalentMSD
00006-4093-02 RECOMBIVAX HBMerck Sharp & Dohme LLC7/23/198600300064093025 7/5/202200006-4093-01 False 00300064093018 2/1/202308 Hep B, adolescent or pediatricMSD
00006-4093-09 RECOMBIVAX HBMerck Sharp & Dohme LLC7/23/19866/13/202300300064093094 7/11/202300006-4093-01 False 00300064093018 2/1/202308 Hep B, adolescent or pediatricMSD
00006-4094-02 RECOMBIVAX HBMerck Sharp & Dohme LLC7/23/198600300064094022 7/5/202200006-4094-01 False 00300064094015 2/1/202343 Hep B, adultMSD
00006-4094-09 RECOMBIVAX HBMerck Sharp & Dohme LLC7/23/19866/13/202300300064094091 7/11/202300006-4094-01 False 00300064094015 2/1/202343 Hep B, adultMSD
00006-4095-02 VAQTAMerck Sharp & Dohme LLC3/29/199600300064095029 7/5/202200006-4095-01 False 00300064095012 2/1/202383 Hep A, ped/adol, 2 doseMSD
00006-4095-09 VAQTAMerck Sharp & Dohme Corp.3/29/19964/30/201900300064095098 5/21/201900006-4095-01 False 00300064095012 2/1/202383 Hep A, ped/adol, 2 doseMSD
00006-4096-02 VAQTAMerck Sharp & Dohme LLC3/29/199600300064096026 7/5/202200006-4096-01 False 00300064096019 2/1/202352 Hep A, adultMSD
00006-4096-09 VAQTAMerck Sharp & Dohme Corp.3/29/19964/30/201900300064096095 5/21/201900006-4096-01 False 00300064096019 2/1/202352 Hep A, adultMSD
00006-4109-02 GARDASILMerck Sharp & Dohme LLC6/8/2006 7/5/202200006-4109-01 False 00300064109016 2/1/202362 HPV, quadrivalentMSD
00006-4109-09 GARDASILMerck Sharp & Dohme LLC6/8/2006 7/5/202200006-4109-01 False 00300064109016 2/1/202362 HPV, quadrivalentMSD
00006-4119-02 GARDASIL 9Merck Sharp & Dohme Corp.12/10/20144/30/201900300064119022 5/29/201900006-4119-01 False 00300064119015 2/1/2023165 HPV9MSD
00006-4119-03 GARDASIL 9Merck Sharp & Dohme LLC12/10/201400300064119039 6/22/202200006-4119-01 False 00300064119015 2/1/2023165 HPV9MSD
00006-4121-02 GARDASIL 9Merck Sharp & Dohme LLC12/10/201400300064121025 6/22/202200006-4121-01 False 00300064121018 2/1/2023165 HPV9MSD
00006-4133-41 Tetanus and Diphtheria Toxoids AdsorbedMerck Sharp & Dohme Corp.7/27/19706/2/2014 7/22/201400006-4133-01 False 7/3/201809 Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbedMSD
00006-4171-00 ProQuadMerck Sharp & Dohme LLC8/1/201500300064171006 7/5/202200006-4171-01 False 00300064171013 2/1/202394 MMRVMSD
00006-4293-02 ERVEBOMerck Sharp & Dohme LLC12/19/2019 1/6/202300006-4293-01 False 2/1/2023204 Ebola Zaire vaccine, live, recombinant, 1mL doseMSD
00006-4329-02 VAXNEUVANCEMerck Sharp & Dohme LLC7/16/202100300064329025 10/17/202200006-4329-01 False 00300064329018 2/1/2023215 Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PFMSD
00006-4329-03 VAXNEUVANCEMerck Sharp & Dohme LLC7/16/202100300064329032 10/17/202200006-4329-01 False 00300064329018 2/1/2023215 Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PFMSD
00006-4347-01 CAPVAXIVEMerck Sharp & Dohme LLC6/17/2024 7/12/202400006-4347-99 False 7/11/2024327 Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PFMSD
00006-4347-02 CAPVAXIVEMerck Sharp & Dohme LLC6/17/2024 7/12/202400006-4347-99 False 7/11/2024327 Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PFMSD
00006-4681-00 M-M-R IIMerck Sharp & Dohme LLC4/21/197100300064681000 6/22/202200006-4681-01 False 00300064681017 2/1/202303 MMRMSD
00006-4739-00 PNEUMOVAX 23Merck Sharp & Dohme Corp.7/7/19834/30/2019 5/21/201900006-4739-01 False 00300064739015 5/21/201933 pneumococcal polysaccharide PPV23MSD
00006-4826-00 VARIVAXMerck Sharp & Dohme LLC3/17/19956/13/202300300064826005 7/11/202300006-4826-01 False 00300064826012 10/26/202321 varicellaMSD
00006-4827-00 VARIVAXMerck Sharp & Dohme LLC3/17/199500300064827002 7/5/202200006-4827-01 False 00300064827019 2/1/202321 varicellaMSD
00006-4831-41 VAQTAMerck Sharp & Dohme LLC3/29/199600300064831412 7/5/202200006-4831-01 False 00300064831016 2/1/202383 Hep A, ped/adol, 2 doseMSD
00006-4837-02 PNEUMOVAX 23Merck Sharp & Dohme Corp.7/21/20141/1/2020 1/21/202000006-4837-01 False 00300064837018 2/1/202333 pneumococcal polysaccharide PPV23MSD
00006-4837-03 PNEUMOVAX 23Merck Sharp & Dohme LLC5/30/201400300064837032 5/30/202300006-4837-01 False 00300064837018 2/1/202333 pneumococcal polysaccharide PPV23MSD
00006-4841-00 VAQTAMerck Sharp & Dohme LLC3/29/199600300064841008 7/5/202200006-4841-01 False 00300064841015 2/1/202352 Hep A, adultMSD
00006-4841-41 VAQTAMerck Sharp & Dohme LLC3/29/199600300064841411 7/5/202200006-4841-01 False 00300064841015 2/1/202352 Hep A, adultMSD
00006-4897-00 PedvaxHIBMerck Sharp & Dohme LLC12/20/198900300064897005 6/22/202200006-4897-01 False 00300064897012 2/1/202349 Hib (PRP-OMP)MSD
00006-4898-00 COMVAXMerck Sharp & Dohme Corp.10/2/199612/31/2014 5/30/201800006-4898-01 False 00300064898019 5/30/201851 Hib-Hep BMSD
00006-4943-00 PNEUMOVAX 23Merck Sharp & Dohme LLC7/7/198300300064943009 6/13/202200006-4943-01 False 00300064943016 2/1/202333 pneumococcal polysaccharide PPV23MSD
00006-4963-00 ZOSTAVAXMerck Sharp & Dohme LLC5/25/20069/19/202200300064963007 10/17/202200006-4963-01 False 00300064963014 10/17/2022121 zoster liveMSD
00006-4963-41 ZOSTAVAXMerck Sharp & Dohme LLC5/25/20069/19/202200300064963410 10/17/202200006-4963-01 False 00300064963014 10/17/2022121 zoster liveMSD
00006-4980-00 RECOMBIVAX HBMerck Sharp & Dohme Corp.7/23/19869/19/2008 7/13/201800006-4980-00 True 11/20/201708 Hep B, adolescent or pediatricMSD
00006-4981-00 RECOMBIVAX HBMerck Sharp & Dohme LLC7/23/198600300064981001 7/5/202200006-4981-01 False 00300064981018 2/1/202308 Hep B, adolescent or pediatricMSD
00006-4992-00 RECOMBIVAX HBMerck Sharp & Dohme LLC7/23/198600300064992007 7/5/202200006-4992-01 False 00300064992014 2/1/202344 Hep B, high-dosage, dialysis or ICMSD
00006-4995-00 RECOMBIVAX HBMerck Sharp & Dohme LLC7/23/198600300064995008 7/5/202200006-4995-01 False 00300064995015 2/1/202343 Hep B, adultMSD
00006-4995-41 RECOMBIVAX HBMerck Sharp & Dohme LLC7/23/198600300064995411 7/5/202200006-4995-01 False 00300064995015 2/1/202343 Hep B, adultMSD
00006-4999-00 ProQuadMerck Sharp & Dohme Corp.9/6/20057/31/201500300064999006 9/13/201800006-4999-01 False 00300064999013 9/13/201894 MMRVMSD
00052-0603-02 BCG VACCINEMerck Sharp & Dohme LLC6/21/1989 6/22/202200052-0603-01 False 2/1/202319 BCGMSD
00069-0297-02 TicoVacPfizer Laboratories Div Pfizer Inc6/27/202200300690297026 10/17/202200069-0297-01 False 10300690297016 2/1/2023223 Tick-borne encephalitis, inactivated, PF, 0.25mLPFR
00069-0297-10 TicoVacPfizer Laboratories Div Pfizer Inc6/27/202200300690297101 10/17/202200069-0297-01 False 10300690297016 2/1/2023223 Tick-borne encephalitis, inactivated, PF, 0.25mLPFR
00069-0344-01 AbrysvoPfizer Laboratories Div Pfizer Inc7/12/202300300690344010 9/17/202400069-0207-01 False 10300690207015 9/17/2024305 RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PFPFR
00069-0344-05 AbrysvoPfizer Laboratories Div Pfizer Inc7/12/202300300690344058 9/17/202400069-0207-01 False 10300690207015 9/17/2024305 RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PFPFR
00069-0344-10 AbrysvoPfizer Laboratories Div Pfizer Inc7/12/202300300690344102 9/17/202400069-0207-01 False 10300690207015 9/17/2024305 RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PFPFR
00069-0411-02 TicoVacPfizer Laboratories Div Pfizer Inc10/25/202100300690411026 10/18/202200069-0411-01 False 10300690411016 2/1/2023224 Tick-borne encephalitis, inactivated, PF, 0.5mLPFR
00069-0411-10 TicoVacPfizer Laboratories Div Pfizer Inc10/25/202100300690411101 10/18/202200069-0411-01 False 10300690411016 2/1/2023224 Tick-borne encephalitis, inactivated, PF, 0.5mLPFR
00069-0600-01 PENBRAYAPfizer Laboratories Div Pfizer Inc11/27/202300300690600017 9/17/202400069-0271-01 False 10300690271016 9/17/2024316 Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PFPFR
00069-0600-01 PENBRAYAPfizer Laboratories Div Pfizer Inc11/27/202300300690600017 9/17/202400069-0332-01 False 10300690332014 9/17/2024316 Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PFPFR
00069-0600-05 PENBRAYAPfizer Laboratories Div Pfizer Inc11/27/202300300690600055 9/17/202400069-0271-01 False 10300690271016 9/17/2024316 Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PFPFR
00069-0600-05 PENBRAYAPfizer Laboratories Div Pfizer Inc11/27/202300300690600055 9/17/202400069-0332-01 False 10300690332014 9/17/2024316 Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PFPFR
00069-0600-10 PENBRAYAPfizer Laboratories Div Pfizer Inc11/27/202300300690600109 9/17/202400069-0271-01 False 10300690271016 9/17/2024316 Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PFPFR
00069-0600-10 PENBRAYAPfizer Laboratories Div Pfizer Inc11/27/202300300690600109 9/17/202400069-0332-01 False 10300690332014 9/17/2024316 Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PFPFR
00069-2025-10 ComirnatyPfizer Laboratories Div Pfizer Inc5/18/20229/11/202300300692025108 2/6/202400069-2025-01 False 10300692025013 2/6/2024217 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrosePFR
00069-2025-25 ComirnatyPfizer Laboratories Div Pfizer Inc3/1/20229/11/202300300692025252 2/6/202400069-2025-01 False 10300692025013 2/6/2024217 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrosePFR
00069-2362-10 ComirnatyPfizer Laboratories Div Pfizer Inc9/11/20238/21/202400300692362104 9/19/202400069-2362-01 False 10300692362019 9/19/2024309 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mLPFR
00069-2377-10 ComirnatyPfizer Laboratories Div Pfizer Inc10/31/20238/21/202400300692377108 9/19/202400069-2377-01 False 10300692377013 9/19/2024309 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mLPFR
00069-2392-10 ComirnatyPfizer Laboratories Div Pfizer Inc9/11/20236/30/2024 7/18/202400069-2392-01 False 7/18/2024309 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mLPFR
00069-2432-10 ComirnatyPfizer Laboratories Div Pfizer Inc8/22/202400300692432104 10/9/202400069-2432-01 False 10300692432019 10/9/2024309 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mLPFR
00069-2465-01 AbrysvoPfizer Laboratories Div Pfizer Inc7/30/2024 8/6/202400069-2465-19 False 8/6/2024305 RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PFPFR
00069-2465-10 AbrysvoPfizer Laboratories Div Pfizer Inc7/30/2024 8/6/202400069-2465-19 False 8/6/2024305 RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PFPFR
13533-0131-01 TDVAXGrifols USA, LLC7/1/201520313533131016 3/12/202413533-0131-00 False 00313533131005 3/12/202409 Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbedMBL
14362-0111-04 TDVAXMassBiologics7/27/197020314362011142 3/12/202414362-0111-03 False 00314362011131 3/12/202409 Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbedMBL
17478-0131-01 Tetanus and Diphtheria Toxoids AdsorbedAkorn, Inc.2/15/20134/27/2017 7/6/201817478-0131-00 False 5/30/201809 Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbedMBL
19515-0808-52 Flulaval QuadrivalentID Biomedical Corporation of Quebec7/1/20226/30/202300319515808521 7/18/202419515-0808-41 False 10319515808412 7/18/2024150 Influenza, split virus, quadrivalent, PFIDB
19515-0810-52 FLULAVALID Biomedical Corporation of Quebec7/1/2024 7/18/202419515-0810-41 False 7/23/2024140 Influenza, split virus, trivalent, PFIDB
19515-0814-52 Flulaval QuadrivalentID Biomedical Corporation of Quebec7/1/20236/30/2024 7/18/202419515-0814-41 False 7/23/2024150 Influenza, split virus, quadrivalent, PFIDB
19515-0816-52 Flulaval QuadrivalentID Biomedical Corporation of Quebec7/2/20206/30/2021 7/18/202419515-0816-41 False 7/18/2024150 Influenza, split virus, quadrivalent, PFIDB
19515-0818-52 Flulaval QuadrivalentID Biomedical Corporation of Quebec7/2/20216/30/202200319515818520 7/18/202419515-0818-41 False 10319515818411 7/18/2024150 Influenza, split virus, quadrivalent, PFIDB
19515-0845-11 FLULAVALID Biomedical10/30/201510/31/2015 7/12/201819515-0845-01 False 7/3/2018141 Influenza, split virus, trivalent, preservativeIDB
19515-0850-52 FLULAVALID Biomedical7/1/201510/31/2015 7/12/201819515-0850-41 False 7/3/2018140 Influenza, split virus, trivalent, PFIDB
19515-0889-07 FLULAVALID Biomedical Corporation of Quebec7/20/20127/1/2013 12/7/201719515-0889-02 False 11/20/2017141 Influenza, split virus, trivalent, preservativeIDB
19515-0890-07 FLULAVALID Biomedical Corporation of Quebec7/1/20136/30/2014 12/7/201719515-0890-02 False 11/20/2017141 Influenza, split virus, trivalent, preservativeIDB
19515-0891-11 Flulaval QuadrivalentID Biomedical Corporation of Quebec7/1/20146/30/2015 5/30/201819515-0891-01 False 5/30/2018158 Influenza, split virus, quadrivalent, preservativeIDB
19515-0893-07 FLULAVALID Biomedical Corporation of Quebec7/1/20146/30/2015 5/30/201819515-0893-02 False 00319515893022 5/30/2018141 Influenza, split virus, trivalent, preservativeIDB
19515-0894-52 Flulaval QuadrivalentID Biomedical Corporation of Quebec7/1/20146/30/2015 5/30/201819515-0894-41 False 5/30/2018150 Influenza, split virus, quadrivalent, PFIDB
19515-0895-11 Flulaval QuadrivalentID Biomedical Corporation of Quebec8/15/20136/30/2014 12/7/201719515-0895-01 False 11/20/2017158 Influenza, split virus, quadrivalent, preservativeIDB
19515-0896-11 Flulaval QuadrivalentID Biomedical Corporation of Quebec7/7/20176/30/201800319515896115 7/9/201819515-0896-01 False 00319515896016 7/9/2018158 Influenza, split virus, quadrivalent, preservativeIDB
19515-0897-11 Flulaval QuadrivalentID Biomedical Corporation of Quebec7/2/20196/30/2020 7/18/202419515-0897-01 False 7/18/2024158 Influenza, split virus, quadrivalent, preservativeIDB
19515-0898-11 Flulaval QuadrivalentID Biomedical Corporation of Quebec7/1/20156/30/2016 5/30/201819515-0898-01 False 00319515898010 5/30/2018158 Influenza, split virus, quadrivalent, preservativeIDB
19515-0900-11 Flulaval QuadrivalentID Biomedical Corporation of Quebec6/29/20186/30/201900319515900119 7/16/201919515-0900-01 False 00319515900010 7/16/2019158 Influenza, split virus, quadrivalent, preservativeIDB
19515-0901-52 Flulaval QuadrivalentID Biomedical Corporation of Quebec7/1/20156/30/2016 5/30/201819515-0901-41 False 00319515901413 5/30/2018150 Influenza, split virus, quadrivalent, PFIDB
19515-0903-11 Flulaval QuadrivalentID Biomedical Corporation of Quebec7/1/20166/30/2017 7/11/201819515-0903-01 False 7/3/2018158 Influenza, split virus, quadrivalent, preservativeIDB
19515-0906-52 Flulaval QuadrivalentID Biomedical Corporation of Quebec7/2/20196/30/2020 7/18/202419515-0906-41 False 7/18/2024150 Influenza, split virus, quadrivalent, PFIDB
19515-0908-52 Flulaval QuadrivalentID Biomedical Corporation of Quebec7/1/20166/30/2017 7/11/201819515-0908-41 False 7/3/2018150 Influenza, split virus, quadrivalent, PFIDB
19515-0909-52 Flulaval QuadrivalentID Biomedical Corporation of Quebec6/29/20186/30/201900319515909525 7/16/201919515-0909-41 False 00319515909419 7/16/2019150 Influenza, split virus, quadrivalent, PFIDB
19515-0912-52 Flulaval QuadrivalentID Biomedical Corporation of Quebec7/7/20176/30/201800319515912525 7/9/201819515-0912-41 False 00319515912419 7/9/2018150 Influenza, split virus, quadrivalent, PFIDB
21695-0413-01 Tetanus and Diphtheria Toxoids AdsorbedRebel Distributors10/13/196710/4/2019 10/15/201921695-0413-01 True 10/11/201909 Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbedMBL
33332-0010-01 AFLURIACSL Limited7/30/20106/30/2011 1/29/201833332-0010-01 True 2/27/2018140 Influenza, split virus, trivalent, PFCSL
33332-0013-01 AFLURIACSL Limited7/1/20136/30/2014 7/13/201833332-0013-02 False 11/20/2017140 Influenza, split virus, trivalent, PFCSL
33332-0014-01 AFLURIACSL Limited7/15/20146/30/2015 12/7/201733332-0014-02 False 7/3/2018140 Influenza, split virus, trivalent, PFCSL
33332-0015-01 AFLURIAbioCSL Pty Ltd.7/1/20156/30/2016 10/8/201933332-0015-02 False 10/8/2019140 Influenza, split virus, trivalent, PFCSL
33332-0016-01 AFLURIASeqirus Pty Ltd7/1/20166/30/2017 7/11/201833332-0016-02 False 7/3/2018140 Influenza, split virus, trivalent, PFSEQ
33332-0017-01 AFLURIASeqirus Pty Ltd7/1/20176/30/2018 8/13/201833332-0017-02 False 8/13/2018140 Influenza, split virus, trivalent, PFSEQ
33332-0018-01 AFLURIASeqirus Pty Ltd7/1/201812/20/2019 1/21/202033332-0018-02 False 1/21/2020140 Influenza, split virus, trivalent, PFSEQ
33332-0024-03 AfluriaSeqirus PTY LTD.7/1/202400333332024032 9/27/202433332-0024-04 False 00333332024049 9/27/2024140 Influenza, split virus, trivalent, PFSEQ
33332-0110-10 AFLURIACSL Limited7/30/20106/30/2011 1/29/201833332-0110-10 True 1/29/2018141 Influenza, split virus, trivalent, preservativeCSL
33332-0113-10 AFLURIACSL Limited7/1/20136/30/2014 7/13/201833332-0113-11 False 7/3/2018141 Influenza, split virus, trivalent, preservativeCSL
33332-0114-10 AFLURIACSL Limited7/15/20146/30/2015 7/13/201833332-0114-11 False 7/3/2018141 Influenza, split virus, trivalent, preservativeCSL
33332-0115-10 AFLURIAbioCSL Pty Ltd.7/1/20156/30/2016 10/8/201933332-0115-11 False 10/8/2019141 Influenza, split virus, trivalent, preservativeCSL
33332-0116-10 AFLURIASeqirus Pty Ltd7/1/20166/30/2017 7/11/201833332-0116-11 False 7/3/2018141 Influenza, split virus, trivalent, preservativeSEQ
33332-0117-10 AFLURIASeqirus Pty Ltd7/1/20176/30/2018 8/13/201833332-0117-11 False 8/13/2018141 Influenza, split virus, trivalent, preservativeSEQ
33332-0118-10 AFLURIASeqirus Pty Ltd7/1/201812/20/2019 1/21/202033332-0118-11 False 1/21/2020141 Influenza, split virus, trivalent, preservativeSEQ
33332-0124-10 AfluriaSeqirus PTY LTD.7/1/202400333332124107 9/27/202433332-0124-11 False 00333332124114 9/27/2024141 Influenza, split virus, trivalent, preservativeSEQ
33332-0219-20 Afluria QuadrivalentSeqirus Pty Ltd.7/2/20197/31/202000333332219209 7/18/202433332-0219-21 False 00333332219216 7/18/2024161 Influenza, injectable,quadrivalent, preservative free, pediatricSEQ
33332-0220-20 Afluria QuadrivalentSeqirus Pty Ltd.7/2/20207/1/2021 7/18/202433332-0220-21 False 7/18/2024161 Influenza, injectable,quadrivalent, preservative free, pediatricSEQ
33332-0221-20 Afluria QuadrivalentSeqirus PTY LTD.7/2/20216/30/2022 7/18/202433332-0221-21 False 7/18/2024161 Influenza, injectable,quadrivalent, preservative free, pediatricSEQ
33332-0316-01 AFLURIA QUADRIVALENTSeqirus7/1/20166/30/2017 7/13/201833332-0316-02 False 7/3/2018150 Influenza, split virus, quadrivalent, PFSEQ
33332-0317-01 AFLURIA QUADRIVALENTSeqirus Pty Ltd7/1/20176/30/2018 8/13/201833332-0317-02 False 8/13/2018150 Influenza, split virus, quadrivalent, PFSEQ
33332-0318-01 AFLURIA QUADRIVALENTSeqirus Pty Ltd7/1/20186/30/2019 12/20/201933332-0318-02 False 12/20/2019150 Influenza, split virus, quadrivalent, PFSEQ
33332-0319-01 Afluria QuadrivalentSeqirus Pty Ltd.7/1/20197/31/202000333332319015 7/18/202433332-0319-02 False 00333332319022 7/18/2024150 Influenza, split virus, quadrivalent, PFSEQ
33332-0320-01 Afluria QuadrivalentSeqirus Pty Ltd.7/2/20207/1/2021 7/18/202433332-0320-02 False 7/18/2024150 Influenza, split virus, quadrivalent, PFSEQ
33332-0321-01 Afluria QuadrivalentSeqirus PTY LTD.7/2/20216/30/2022 7/18/202433332-0321-02 False 7/18/2024150 Influenza, split virus, quadrivalent, PFSEQ
33332-0322-03 Afluria QuadrivalentSeqirus PTY LTD.7/1/20226/30/202300333332322039 7/18/202433332-0322-04 False 00333332322046 7/18/2024150 Influenza, split virus, quadrivalent, PFSEQ
33332-0323-03 Afluria QuadrivalentSeqirus PTY LTD.7/1/20236/30/202400333332323036 8/6/202433332-0323-04 False 00333332323043 8/6/2024150 Influenza, split virus, quadrivalent, PFSEQ
33332-0416-10 AFLURIA QUADRIVALENTSeqirus7/1/20166/30/2017 7/13/201833332-0416-11 False 7/3/2018158 Influenza, split virus, quadrivalent, preservativeSEQ
33332-0417-10 AFLURIA QUADRIVALENTSeqirus Pty Ltd8/16/20176/30/2018 8/13/201833332-0417-11 False 8/13/2018158 Influenza, split virus, quadrivalent, preservativeSEQ
33332-0418-10 AFLURIA QUADRIVALENTSeqirus Pty Ltd7/1/20186/30/2019 12/20/201933332-0418-11 False 12/20/2019158 Influenza, split virus, quadrivalent, preservativeSEQ
33332-0419-10 Afluria QuadrivalentSeqirus Pty Ltd.7/1/20197/31/202000333332419104 7/18/202433332-0419-11 False 00333332419111 7/18/2024158 Influenza, split virus, quadrivalent, preservativeSEQ
33332-0420-10 Afluria QuadrivalentSeqirus Pty Ltd.7/2/20207/1/2021 7/18/202433332-0420-11 False 7/18/2024158 Influenza, split virus, quadrivalent, preservativeSEQ
33332-0421-10 Afluria QuadrivalentSeqirus PTY LTD.7/2/20216/30/2022 7/18/202433332-0421-11 False 7/18/2024158 Influenza, split virus, quadrivalent, preservativeSEQ
33332-0422-10 Afluria QuadrivalentSeqirus PTY LTD.7/1/20226/30/2023 7/18/202433332-0422-11 False 00333332422111 7/18/2024158 Influenza, split virus, quadrivalent, preservativeSEQ
33332-0423-10 Afluria QuadrivalentSeqirus PTY LTD.7/1/20236/30/202400333332423101 8/6/202433332-0423-11 False 00333332423118 8/6/2024158 Influenza, split virus, quadrivalent, preservativeSEQ
33332-0519-01 Influenza ACSL Limited7/1/20096/30/2010 1/29/201833332-0519-01 True 1/29/2018126 Novel influenza-H1N1-09, preservative-freeCSL
33332-0519-25 Influenza ACSL Limited7/1/20096/30/2010 1/29/201833332-0519-25 True 1/29/2018126 Novel influenza-H1N1-09, preservative-freeCSL
33332-0629-10 Influenza ACSL Limited7/1/20096/30/2010 1/29/201833332-0629-10 True 1/29/2018127 Novel influenza-H1N1-09CSL
42515-0001-01 IXIAROValneva Scotland Ltd.3/30/20092/13/2018 3/7/202342515-0001-01 True 10/15/2019134 Japanese Encephalitis IMVAL
42515-0001-01 IXIAROValneva Scotland Ltd.3/30/20092/13/2018 3/7/202342515-0001-01 True 10/15/2019134 Japanese Encephalitis IMINT
42515-0001-01 IXIAROValneva Scotland Ltd.3/30/20092/13/2018 3/7/202342515-0001-00 False 3/7/2023134 Japanese Encephalitis IMVAL
42515-0001-01 IXIAROValneva Scotland Ltd.3/30/20092/13/2018 3/7/202342515-0001-00 False 3/7/2023134 Japanese Encephalitis IMINT
42515-0002-01 IXIAROValneva Scotland Ltd.3/30/2009 7/12/201842515-0002-01 True 4/6/2018134 Japanese Encephalitis IMVAL
42515-0003-01 IXCHIQValneva Scotland Ltd.1/15/202400342515003016 9/27/202442515-0003-00 False 10/9/2024317 Chikungunya live attenuated vaccine, 0.5 mL, PFVAL
42874-0012-10 FlublokProtein Sciences Corporation2/1/20136/30/2013 10/8/201942874-0012-01 False 10/8/2019155 Influenza, recombinant, trivalent, PFPSC
42874-0013-10 FlublokProtein Sciences Corporation11/1/20136/30/2014 10/8/201942874-0013-01 False 10/8/2019155 Influenza, recombinant, trivalent, PFPSC
42874-0014-10 FlublokProtein Sciences Corporation9/15/20146/30/2015 10/8/201942874-0014-01 False 10/8/2019155 Influenza, recombinant, trivalent, PFPSC
42874-0015-10 FlublokProtein Sciences Corporation8/7/20156/30/2016 10/8/201942874-0015-01 False 10/8/2019155 Influenza, recombinant, trivalent, PFPSC
42874-0016-10 FlublokProtein Sciences Corporation8/1/20166/30/2017 10/8/201942874-0016-01 False 10/8/2019155 Influenza, recombinant, trivalent, PFPSC
42874-0017-10 FlublokProtein Sciences Corporation7/14/20176/30/2018 10/8/201942874-0017-01 False 10/8/2019155 Influenza, recombinant, trivalent, PFPSC
42874-0117-10 Flublok QuadrivalentProtein Sciences Corporation7/14/20176/30/2018 7/9/201842874-0117-01 False 7/9/2018185 Influenza, recombinant, quadrivalent, PFPSC
43528-0002-05 HEPLISAV-BDynavax Technologies Corporation1/1/201812/20/201900343528002058 1/21/202043528-0002-01 False 00343528002010 1/21/2020189 HepB-CpGDVX
43528-0003-05 HEPLISAV-BDynavax Technologies Corporation1/1/201800343528003055 2/2/202343528-0003-01 False 00343528003017 2/2/2023189 HepB-CpGDVX
46028-0114-01 BexseroNovartis Vaccines and Diagnostics SRL1/23/201510/31/2017 5/30/201846028-0114-11 False 5/30/2018163 meningococcal B, OMVNOV
46028-0114-02 BexseroNovartis Vaccines and Diagnostics SRL1/23/201510/31/2017 5/30/201846028-0114-11 False 5/30/2018163 meningococcal B, OMVNOV
46028-0208-01 MenveoNovartis Vaccines and Diagnostics s.r.l.2/19/20104/30/2018 12/16/202246028-0219-11 False 00346028219117 5/16/2018136 Meningococcal MCV4ONOV
46028-0208-01 MenveoNovartis Vaccines and Diagnostics s.r.l.2/19/20104/30/2018 12/16/202246028-0218-11 False 00346028218110 5/16/2018136 Meningococcal MCV4ONOV
49281-0010-10 FLUZONESanofi Pasteur Inc.7/23/20106/30/2011 1/29/201849281-0010-10 True 00349281010101 7/4/2018140 Influenza, split virus, trivalent, PFPMC
49281-0010-25 FLUZONESanofi Pasteur Inc.7/23/20106/30/2011 1/29/201849281-0010-25 True 00349281010255 9/19/2018140 Influenza, split virus, trivalent, PFPMC
49281-0010-50 FLUZONESanofi Pasteur Inc.7/23/20106/30/2011 1/29/201849281-0010-50 True 00349281010507 7/4/2018140 Influenza, split virus, trivalent, PFPMC
49281-0011-10 FLUZONESanofi Pasteur Inc.7/1/20116/30/2012 1/29/201849281-0011-10 True 00349281011108 2/13/2018140 Influenza, split virus, trivalent, PFPMC
49281-0011-50 FLUZONESanofi Pasteur Inc.7/1/20116/30/2012 1/29/201849281-0011-50 True 00349281011504 1/29/2018140 Influenza, split virus, trivalent, PFPMC
49281-0012-10 FLUZONESanofi Pasteur Inc.7/2/20126/30/2013 12/7/201749281-0012-10 True 00349281012105 7/4/2018140 Influenza, split virus, trivalent, PFPMC
49281-0012-50 FLUZONESanofi Pasteur Inc.7/2/20126/30/2013 12/7/201749281-0012-50 True 00349281012501 11/20/2017140 Influenza, split virus, trivalent, PFPMC
49281-0013-10 FLUZONESanofi Pasteur Inc.6/28/20136/30/2014 12/7/201749281-0013-58 False 00349281013584 11/20/2017140 Influenza, split virus, trivalent, PFPMC
49281-0013-50 FLUZONESanofi Pasteur Inc.6/28/20136/30/2014 12/7/201749281-0013-88 False 00349281013881 11/20/2017140 Influenza, split virus, trivalent, PFPMC
49281-0014-50 FLUZONESanofi Pasteur Inc.6/27/20146/30/2015 7/6/201849281-0014-88 False 00349281014888 7/4/2018140 Influenza, split virus, trivalent, PFPMC
49281-0111-25 FLUZONESanofi Pasteur Inc.7/1/20116/30/2012 1/29/201849281-0111-25 True 00349281111259 7/4/2018140 Influenza, split virus, trivalent, PFPMC
49281-0112-25 FLUZONESanofi Pasteur Inc.7/2/20126/30/2013 12/7/201749281-0112-25 True 00349281112256 7/4/2018140 Influenza, split virus, trivalent, PFPMC
49281-0113-25 FLUZONESanofi Pasteur Inc.6/28/20136/30/2014 12/7/201749281-0113-00 False 00349281113000 11/20/2017140 Influenza, split virus, trivalent, PFPMC
49281-0120-65 FLUZONE High-Dose Quadrivalent Northern HemisphereSanofi Pasteur Inc.11/1/20196/30/2021 7/18/202449281-0120-88 False 7/18/2024197 Influenza, high-dose, quadrivalent, PFPMC
49281-0121-65 FLUZONE High-Dose Quadrivalent Northern HemisphereSanofi Pasteur Inc.7/2/20216/30/202200349281121654 7/18/202449281-0121-88 False 00349281121883 7/18/2024197 Influenza, high-dose, quadrivalent, PFPMC
49281-0122-65 FLUZONE High-Dose Quadrivalent Northern HemisphereSanofi Pasteur Inc.7/1/20226/30/202300349281122651 7/18/202449281-0122-88 False 00349281122880 7/18/2024197 Influenza, high-dose, quadrivalent, PFPMC
49281-0123-65 Fluzone High-Dose Quadrivalent Northern HemisphereSanofi Pasteur Inc.6/30/20236/30/202400349281123658 9/19/202449281-0123-88 False 00349281123887 9/19/2024197 Influenza, high-dose, quadrivalent, PFPMC
49281-0124-65 FLUZONE HIGH DOSE NORTHERN HEMISPHERESanofi Pasteur Inc.7/1/202400349281124655 9/27/202449281-0124-88 False 00349281124884 9/27/2024135 Influenza, high-dose, trivalent, PFPMC
49281-0181-25 FLUZONE QUADRIVALENT SOUTHERN HEMISPHERESanofi Pasteur Inc.9/30/201912/31/2020 7/18/202449281-0181-00 False 7/18/2024200 influenza, Southern Hemisphere, pediatric, preservative freePMC
49281-0182-25 FLUZONE QUADRIVALENT SOUTHERN HEMISPHERESanofi Pasteur Inc.2/4/202112/31/202100349281182259 7/18/202449281-0182-00 False 00349281182006 7/18/2024200 influenza, Southern Hemisphere, pediatric, preservative freePMC
49281-0215-10 TENIVACSanofi Pasteur Inc.12/8/201000349281215100 2/2/202349281-0215-58 False 00349281215582 2/2/2023113 Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbedPMC
49281-0215-15 TENIVACSanofi Pasteur Inc.12/8/201000349281215155 2/2/202349281-0215-88 False 00349281215889 2/22/2023113 Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbedPMC
49281-0225-10 DIPHTHERIA AND TETANUS TOXOIDS ADSORBEDSanofi Pasteur Inc.3/29/20104/30/202300349281225109 11/5/202449281-0225-58 False 00349281225581 11/5/202428 DT (pediatric)PMC
49281-0250-51 IMOVAX RABIESSanofi Pasteur Inc.9/30/201312/7/202100349281250514 12/13/202149281-0248-58 False 00349281248580 5/16/2022175 Rabies - IM Diploid cell culturePMC
49281-0252-51 IMOVAX RABIESSanofi Pasteur Inc.10/25/201900349281252518 2/2/202349281-0246-58 False 00349281246586 2/2/2023175 Rabies - IM Diploid cell culturePMC
49281-0278-10 DIPHTHERIA AND TETANUS TOXOIDS ADSORBEDSanofi Pasteur Inc.9/18/19843/18/2013 1/29/201849281-0278-10 True 1/29/201828 DT (pediatric)PMC
49281-0286-01 DAPTACELSanofi Pasteur Inc.5/14/200200349281286018 4/24/202349281-0286-58 False 00349281286582 2/1/2023106 DTaP, 5 pertussis antigensPMC
49281-0286-05 DAPTACELSanofi Pasteur Inc.5/14/200200349281286056 1/31/202249281-0286-58 False 00349281286582 2/1/2023106 DTaP, 5 pertussis antigensPMC
49281-0286-10 DAPTACELSanofi Pasteur Inc.5/14/200200349281286100 1/31/202249281-0286-58 False 00349281286582 2/1/2023106 DTaP, 5 pertussis antigensPMC
49281-0291-10 DECAVACSanofi Pasteur Inc.3/24/200412/31/2012 5/30/201849281-0291-10 True 5/30/2018113 Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbedPMC
49281-0291-83 DECAVACSanofi Pasteur Inc.3/24/200412/31/2012 5/30/201849281-0291-83 True 6/8/2018113 Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbedPMC
49281-0298-10 TRIPEDIASanofi Pasteur Inc.8/20/19923/13/2013 1/29/201849281-0298-10 True 1/29/201820 DTaPPMC
49281-0320-50 FLUZONE QUADRIVALENT SOUTHERN HEMISPHERESanofi Pasteur Inc.9/30/201912/31/2020 7/18/202449281-0320-88 False 7/18/2024201 influenza, Southern Hemisphere, preservative freePMC
49281-0321-50 FLUZONE QUADRIVALENT SOUTHERN HEMISPHERESanofi Pasteur Inc.2/4/202112/31/202100349281321504 7/18/202449281-0321-88 False 00349281321887 7/18/2024201 influenza, Southern Hemisphere, preservative freePMC
49281-0322-50 FLUZONE QUADRIVALENT SOUTHERN HEMISPHERESanofi Pasteur Inc.2/15/202212/31/202200349281322501 7/18/202449281-0322-88 False 00349281322884 7/18/2024201 influenza, Southern Hemisphere, preservative freePMC
49281-0323-50 FLUZONE QUADRIVALENT SOUTHERN HEMISPHERESanofi Pasteur Inc.2/13/202312/31/2023 7/18/202449281-0323-88 False 7/18/2024201 influenza, Southern Hemisphere, preservative freePMC
49281-0324-50 FLUZONE QUADRIVALENT SOUTHERN HEMISPHERESanofi Pasteur Inc.2/14/202400349281324505 9/19/202449281-0324-88 False 00349281324888 9/19/2024201 influenza, Southern Hemisphere, preservative freePMC
49281-0336-15 FLUZONE QUADRIVALENT SOUTHERN HEMISPHERESanofi Pasteur Inc.9/30/201912/31/2020 7/18/202449281-0336-78 False 7/18/2024202 influenza, Southern Hemisphere, quadrivalent, with preservativePMC
49281-0337-15 FLUZONE QUADRIVALENT SOUTHERN HEMISPHERESanofi Pasteur Inc.2/4/202112/31/202100349281337154 7/18/202449281-0337-78 False 00349281337789 7/18/2024202 influenza, Southern Hemisphere, quadrivalent, with preservativePMC
49281-0339-15 FLUZONE QUADRIVALENT SOUTHERN HEMISPHERESanofi Pasteur Inc.2/15/202212/31/202200349281339158 7/18/202449281-0339-78 False 00349281339783 7/18/2024202 influenza, Southern Hemisphere, quadrivalent, with preservativePMC
49281-0355-15 FLUZONE QUADRIVALENT SOUTHERN HEMISPHERESanofi Pasteur Inc.2/13/202312/31/2023 7/18/202449281-0355-78 False 7/18/2024202 influenza, Southern Hemisphere, quadrivalent, with preservativePMC
49281-0379-50 FLUZONE High-Dose Quadrivalent Southern HemisphereSanofi Pasteur Inc.2/13/202312/31/2023 7/18/202449281-0379-88 False 7/18/2024231 influenza, Southern Hemisphere, high-dose, quadrivalentPMC
49281-0386-15 FLUZONESanofi Pasteur Inc.7/23/20106/30/2011 1/29/201849281-0386-15 True 00349281386152 7/4/2018141 Influenza, split virus, trivalent, preservativePMC
49281-0387-65 FLUZONESanofi Pasteur Inc.7/23/20106/30/2011 1/29/201849281-0387-65 True 00349281387654 7/4/2018135 Influenza, high-dose, trivalent, PFPMC
49281-0388-15 FLUZONESanofi Pasteur Inc.7/1/20116/30/2012 1/29/201849281-0388-15 True 00349281388156 1/29/2018141 Influenza, split virus, trivalent, preservativePMC
49281-0389-65 FLUZONE HIGH DOSESanofi Pasteur Inc.7/1/20116/30/2012 2/27/201849281-0389-65 True 00349281389658 7/4/2018135 Influenza, high-dose, trivalent, PFPMC
49281-0390-15 FLUZONESanofi Pasteur Inc.7/2/20126/30/2013 12/7/201749281-0390-15 True 00349281390159 7/4/2018141 Influenza, split virus, trivalent, preservativePMC
49281-0391-65 FLUZONE High-DoseSanofi Pasteur Inc.7/2/20126/30/2013 12/7/201749281-0391-65 True 00349281391651 7/4/2018135 Influenza, high-dose, trivalent, PFPMC
49281-0392-15 FLUZONESanofi Pasteur Inc.6/28/20136/30/2014 12/7/201749281-0392-78 False 00349281392788 11/20/2017141 Influenza, split virus, trivalent, preservativePMC
49281-0393-65 FLUZONE High-DoseSanofi Pasteur Inc.6/28/20136/30/2014 12/7/201749281-0393-88 False 00349281393884 11/20/2017135 Influenza, high-dose, trivalent, PFPMC
49281-0394-15 FLUZONESanofi Pasteur Inc.6/27/20146/30/2015 7/6/201849281-0394-78 False 7/4/2018141 Influenza, split virus, trivalent, preservativePMC
49281-0395-65 FLUZONE High-DoseSanofi Pasteur Inc.6/27/20146/30/2015 6/27/201849281-0395-88 False 7/4/2018135 Influenza, high-dose, trivalent, PFPMC
49281-0396-15 FLUZONESanofi Pasteur Inc.6/26/20156/30/2016 12/7/201749281-0396-78 False 00349281396786 11/20/2017141 Influenza, split virus, trivalent, preservativePMC
49281-0397-65 FLUZONE High-DoseSanofi Pasteur Inc.6/26/20156/30/2016 12/7/201749281-0397-88 False 00349281397882 11/20/2017135 Influenza, high-dose, trivalent, PFPMC
49281-0398-15 FLUZONE QUADRIVALENT SOUTHERN HEMISPHERESanofi Pasteur Inc.2/14/2024 7/18/202449281-0398-78 False 7/18/2024202 influenza, Southern Hemisphere, quadrivalent, with preservativePMC
49281-0399-65 FLUZONE High-DoseSanofi Pasteur Inc.7/1/20166/30/2017 7/11/201849281-0399-88 False 5/30/2018135 Influenza, high-dose, trivalent, PFPMC
49281-0400-05 AdacelSanofi Pasteur Inc.6/10/200500349281400056 4/24/202349281-0400-58 False 00349281400582 2/1/2023115 TdapPMC
49281-0400-10 AdacelSanofi Pasteur Inc.6/10/200500349281400100 1/31/202249281-0400-58 False 00349281400582 2/1/2023115 TdapPMC
49281-0400-15 AdacelSanofi Pasteur Inc.10/1/20131/20/2021 1/28/202149281-0400-88 False 00349281400889 1/25/2021115 TdapPMC
49281-0400-20 AdacelSanofi Pasteur Inc.6/10/200500349281400209 1/31/202249281-0400-89 False 00349281400896 2/1/2023115 TdapPMC
49281-0401-65 FLUZONE High-DoseSanofi Pasteur Inc.7/1/20176/30/2018 7/9/201849281-0401-88 False 7/9/2018135 Influenza, high-dose, trivalent, PFPMC
49281-0403-65 FLUZONE High-DoseSanofi Pasteur Inc.6/29/20186/30/2019 5/3/202349281-0403-88 False 00349281403880 5/3/2023135 Influenza, high-dose, trivalent, PFPMC
49281-0405-65 FLUZONE High-DoseSanofi Pasteur Inc.7/1/20196/30/2020 7/18/202449281-0405-88 False 00349281405884 7/18/2024135 Influenza, high-dose, trivalent, PFPMC
49281-0413-10 FLUZONE QUADRIVALENTSanofi Pasteur Inc.6/10/20136/30/2014 12/7/201749281-0413-58 False 00349281413582 11/20/2017150 Influenza, split virus, quadrivalent, PFPMC
49281-0413-50 FLUZONE QUADRIVALENTSanofi Pasteur Inc.6/10/20136/30/2014 12/7/201749281-0413-88 False 00349281413889 11/20/2017150 Influenza, split virus, quadrivalent, PFPMC
49281-0414-10 FLUZONE QUADRIVALENTSanofi Pasteur Inc.6/27/20146/30/2015 7/13/201849281-0414-58 False 00349281414589 7/5/2018150 Influenza, split virus, quadrivalent, PFPMC
49281-0414-50 FLUZONE QUADRIVALENTSanofi Pasteur Inc.6/27/20146/30/2015 7/12/201849281-0414-88 False 00349281414886 7/5/2018150 Influenza, split virus, quadrivalent, PFPMC
49281-0415-10 FLUZONE QUADRIVALENTSanofi Pasteur Inc.6/26/20156/30/2016 7/12/201849281-0415-58 False 00349281415586 5/30/2018150 Influenza, split virus, quadrivalent, PFPMC
49281-0416-10 FLUZONE QUADRIVALENTSanofi Pasteur Inc.7/1/20166/30/2017 7/11/201849281-0416-58 False 5/30/2018150 Influenza, split virus, quadrivalent, PFPMC
49281-0416-50 FLUZONE QUADRIVALENTSanofi Pasteur Inc.7/1/20166/30/2017 7/11/201849281-0416-88 False 5/30/2018150 Influenza, split virus, quadrivalent, PFPMC
49281-0417-10 FLUZONE QUADRIVALENTSanofi Pasteur Inc.7/1/20176/30/2018 7/13/201849281-0417-58 False 00349281417580 7/9/2018150 Influenza, split virus, quadrivalent, PFPMC
49281-0417-50 FLUZONE QUADRIVALENTSanofi Pasteur Inc.7/1/20176/30/2018 7/13/201849281-0417-88 False 00349281417887 7/9/2018150 Influenza, split virus, quadrivalent, PFPMC
49281-0418-10 FLUZONE QUADRIVALENTSanofi Pasteur Inc.6/29/20186/30/2019 7/16/201949281-0418-58 False 00349281418587 7/16/2019150 Influenza, split virus, quadrivalent, PFPMC
49281-0418-50 FLUZONE QUADRIVALENT NORTHERN HEMISPHERESanofi Pasteur Inc.6/29/20186/30/2019 8/6/202449281-0418-88 False 00349281418884 8/6/2024150 Influenza, split virus, quadrivalent, PFPMC
49281-0419-10 FLUZONE QUADRIVALENTSanofi Pasteur Inc.7/1/20196/30/2020 7/18/202449281-0419-58 False 00349281419584 7/18/2024150 Influenza, split virus, quadrivalent, PFPMC
49281-0419-50 FLUZONE QUADRIVALENTSanofi Pasteur Inc.7/1/20196/30/2020 7/18/202449281-0419-88 False 00349281419881 7/18/2024150 Influenza, split virus, quadrivalent, PFPMC
49281-0420-10 FLUZONE QUADRIVALENTSanofi Pasteur Inc.7/1/20206/30/2021 7/18/202449281-0420-58 False 7/18/2024150 Influenza, split virus, quadrivalent, PFPMC
49281-0420-50 FLUZONE QUADRIVALENT NORTHERN HEMISPHERESanofi Pasteur Inc.7/1/20206/30/2021 8/6/202449281-0420-88 False 8/6/2024150 Influenza, split virus, quadrivalent, PFPMC
49281-0421-10 FLUZONE QUADRIVALENT NORTHERN HEMISPHERESanofi Pasteur Inc.7/1/20216/30/202200349281421105 8/6/202449281-0421-58 False 00349281421587 8/6/2024150 Influenza, split virus, quadrivalent, PFPMC
49281-0421-50 FLUZONE QUADRIVALENT NORTHERN HEMISPHERESanofi Pasteur Inc.7/2/20216/30/202200349281421501 8/6/202449281-0421-88 False 00349281421884 8/6/2024150 Influenza, split virus, quadrivalent, PFPMC
49281-0422-10 FLUZONE QUADRIVALENT NORTHERN HEMISPHERESanofi Pasteur Inc.7/1/20226/30/202300349281422102 8/6/202449281-0422-58 False 00349281422584 8/6/2024150 Influenza, split virus, quadrivalent, PFPMC
49281-0422-50 FLUZONE QUADRIVALENT NORTHERN HEMISPHERESanofi Pasteur Inc.7/1/20226/30/202300349281422508 8/6/202449281-0422-88 False 00349281422881 8/6/2024150 Influenza, split virus, quadrivalent, PFPMC
49281-0423-50 Fluzone Quadrivalent Northern HemisphereSanofi Pasteur Inc.6/30/20236/30/202400349281423505 9/19/202449281-0423-88 False 00349281423888 9/19/2024150 Influenza, split virus, quadrivalent, PFPMC
49281-0424-50 FLUZONE TRIVALENT NORTHERN HEMISPHERESanofi Pasteur Inc.7/1/202400349281424502 9/27/202449281-0424-88 False 00349281424885 9/27/2024140 Influenza, split virus, trivalent, PFPMC
49281-0489-01 MENOMUNE - A/C/Y/W-135 COMBINEDSanofi Pasteur Inc.11/23/19814/30/2019 5/29/201949281-0487-58 False 00349281487583 5/21/201932 meningococcal MPSV4PMC
49281-0489-91 MENOMUNE - A/C/Y/W-135 COMBINEDSanofi Pasteur Inc.11/23/19819/30/2017 7/12/201849281-0488-78 False 00349281488788 5/21/201932 meningococcal MPSV4PMC
49281-0510-05 PENTACELSanofi Pasteur Inc.6/20/200811/9/202200349281510052 11/29/202249281-0545-15 False 00349281545153 8/22/2019120 DTaP-Hib-IPVPMC
49281-0510-05 PENTACELSanofi Pasteur Inc.6/20/200811/9/202200349281510052 11/29/202249281-0560-05 False 00349281560057 11/29/2022120 DTaP-Hib-IPVPMC
49281-0510-05 PENTACELSanofi Pasteur Inc.6/20/200811/9/202200349281510052 11/29/202249281-0548-58 False 00349281548581 11/29/2022120 DTaP-Hib-IPVPMC
49281-0511-05 PENTACELSanofi Pasteur Inc.1/1/202000349281511059 11/8/202149281-0561-01 False 00349281561016 11/8/2021120 DTaP-Hib-IPVPMC
49281-0511-05 PENTACELSanofi Pasteur Inc.1/1/202000349281511059 11/8/202149281-0544-58 False 00349281544583 11/8/2021120 DTaP-Hib-IPVPMC
49281-0513-25 FLUZONE QUADRIVALENTSanofi Pasteur Inc.6/10/20136/30/2014 12/7/201749281-0513-00 False 00349281513008 11/20/2017161 Influenza, injectable,quadrivalent, preservative free, pediatricPMC
49281-0514-25 FLUZONE QUADRIVALENTSanofi Pasteur Inc.6/27/20146/30/2015 7/13/201849281-0514-00 False 00349281514005 7/5/2018161 Influenza, injectable,quadrivalent, preservative free, pediatricPMC
49281-0516-25 FLUZONE QUADRIVALENTSanofi Pasteur Inc.7/1/20166/30/2017 7/11/201849281-0516-00 False 5/30/2018161 Influenza, injectable,quadrivalent, preservative free, pediatricPMC
49281-0517-25 FLUZONE QUADRIVALENTSanofi Pasteur Inc.7/1/20176/30/2018 7/13/201849281-0517-00 False 00349281517006 7/9/2018161 Influenza, injectable,quadrivalent, preservative free, pediatricPMC
49281-0518-25 FLUZONE QUADRIVALENTSanofi Pasteur Inc.6/29/20186/30/2019 7/16/201949281-0518-00 False 00349281518003 7/16/2019161 Influenza, injectable,quadrivalent, preservative free, pediatricPMC
49281-0519-25 FLUZONE QUADRIVALENT NORTHERN HEMISPHERESanofi Pasteur Inc.7/1/20196/30/2020 8/6/202449281-0519-00 False 00349281519000 8/6/2024161 Influenza, injectable,quadrivalent, preservative free, pediatricPMC
49281-0520-25 FLUZONE QUADRIVALENTSanofi Pasteur Inc.7/1/20206/30/2021 7/18/202449281-0520-00 False 7/18/2024161 Influenza, injectable,quadrivalent, preservative free, pediatricPMC
49281-0521-25 FLUZONE QUADRIVALENTSanofi Pasteur Inc.7/2/20216/30/202200349281521256 7/18/202449281-0521-00 False 00349281521003 7/18/2024161 Influenza, injectable,quadrivalent, preservative free, pediatricPMC
49281-0545-03 ActHIBSanofi Pasteur Inc.5/31/201600349281545030 11/8/202149281-0547-58 False 00349281547584 10/30/201548 Hib (PRP-T)PMC
49281-0545-05 ActHIBSanofi Pasteur Inc.3/30/199311/28/2016 7/12/201849281-0547-58 False 00349281547584 10/30/201548 Hib (PRP-T)PMC
49281-0562-10 QUADRACELSanofi Pasteur Inc.3/24/201510/11/202400349281562105 10/16/202449281-0562-58 False 00349281562587 10/16/2024130 DTaP-IPVPMC
49281-0564-10 QUADRACELSanofi Pasteur Inc.2/6/202000349281564109 9/19/202449281-0564-58 False 00349281564581 9/19/2024130 DTaP-IPVPMC
49281-0564-15 QUADRACELSanofi Pasteur Inc.2/4/202200349281564154 10/17/202249281-0564-88 False 00349281564888 2/1/2023130 DTaP-IPVPMC
49281-0574-15 BEYFORTUSSanofi Pasteur Inc.7/18/202300349281574153 9/19/202449281-0574-88 False 00349281574887 9/19/2024307 RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 monthsPMC
49281-0575-15 BEYFORTUSSanofi Pasteur Inc.7/18/202300349281575150 9/19/202449281-0575-00 False 00349281575006 9/19/2024306 RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 monthsPMC
49281-0589-05 MenactraSanofi Pasteur Inc.1/14/200510/1/202200349281589058 6/11/202449281-0589-58 False 00349281589584 6/11/2024114 meningococcal MCV4PPMC
49281-0590-01 MenQuadfiSanofi Pasteur Inc.4/23/202000349281590016 9/19/202449281-0590-58 False 00349281590580 4/23/2024203 meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)PMC
49281-0590-05 MenQuadfiSanofi Pasteur Inc.4/23/202000349281590054 4/23/202449281-0590-58 False 00349281590580 4/23/2024203 meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)PMC
49281-0590-10 MenQuadfiSanofi Pasteur Inc.4/23/2020 5/9/202449281-0590-58 False 00349281590580 4/23/2024203 meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)PMC
49281-0605-01 DengvaxiaSanofi Pasteur Inc.5/1/201900349281605017 10/24/202349281-0606-58 False 00349281606588 10/24/202356 dengue fever tetravalentPMC
49281-0618-20 ANTIGEN COMPONENTSanofi Pasteur Inc.4/1/202210/31/2022 1/10/202349281-0618-78 False 1/10/2023225 COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mLPMC
49281-0621-15 FLUZONE QUADRIVALENTSanofi Pasteur Inc.6/27/20146/30/2015 7/6/201849281-0621-78 False 11/20/2017158 Influenza, split virus, quadrivalent, preservativePMC
49281-0625-15 FLUZONE QUADRIVALENTSanofi Pasteur Inc.7/1/20166/30/2017 7/11/201849281-0625-78 False 5/30/2018158 Influenza, split virus, quadrivalent, preservativePMC
49281-0627-15 FLUZONE QUADRIVALENTSanofi Pasteur Inc.7/1/20176/30/2018 7/13/201849281-0627-78 False 7/9/2018158 Influenza, split virus, quadrivalent, preservativePMC
49281-0629-15 FLUZONE QUADRIVALENT NORTHERN HEMISPHERESanofi Pasteur Inc.6/29/20186/30/2019 8/6/202449281-0629-78 False 00349281629785 8/6/2024158 Influenza, split virus, quadrivalent, preservativePMC
49281-0631-15 FLUZONE QUADRIVALENT NORTHERN HEMISPHERESanofi Pasteur Inc.7/1/20196/30/2020 8/6/202449281-0631-78 False 00349281631788 8/6/2024158 Influenza, split virus, quadrivalent, preservativePMC
49281-0633-15 FLUZONE QUADRIVALENT NORTHERN HEMISPHERESanofi Pasteur Inc.7/1/20206/30/2021 8/6/202449281-0633-78 False 8/6/2024158 Influenza, split virus, quadrivalent, preservativePMC
49281-0635-15 FLUZONE QUADRIVALENT NORTHERN HEMISPHERESanofi Pasteur Inc.7/2/20216/30/202200349281635151 8/6/202449281-0635-78 False 00349281635786 8/6/2024158 Influenza, split virus, quadrivalent, preservativePMC
49281-0637-15 FLUZONE QUADRIVALENT NORTHERN HEMISPHERESanofi Pasteur Inc.7/1/20226/30/202300349281637155 8/6/202449281-0637-78 False 00349281637780 8/6/2024158 Influenza, split virus, quadrivalent, preservativePMC
49281-0639-15 Fluzone Quadrivalent Northern HemisphereSanofi Pasteur Inc.6/30/20236/30/202400349281639159 9/19/202449281-0639-78 False 00349281639784 9/19/2024158 Influenza, split virus, quadrivalent, preservativePMC
49281-0640-15 INFLUENZA A (H1N1) 2009 MONOVALENT VACCINESanofi Pasteur Inc.9/15/20093/3/2017 5/30/201849281-0640-15 True 6/8/2018127 Novel influenza-H1N1-09PMC
49281-0641-15 FLUZONE TRIVALENT NORTHERN HEMISPHERESanofi Pasteur Inc.7/1/202400349281641152 9/27/202449281-0641-78 False 00349281641787 9/27/2024141 Influenza, split virus, trivalent, preservativePMC
49281-0650-10 INFLUENZA A (H1N1) 2009 MONOVALENT VACCINESanofi Pasteur Inc.9/15/20096/30/2010 10/15/201949281-0650-10 True 10/15/2019126 Novel influenza-H1N1-09, preservative-freePMC
49281-0650-25 INFLUENZA A (H1N1) 2009 MONOVALENT VACCINESanofi Pasteur Inc.9/15/20096/30/2010 10/15/201949281-0650-25 True 10/15/2019126 Novel influenza-H1N1-09, preservative-freePMC
49281-0650-50 INFLUENZA A (H1N1) 2009 MONOVALENT VACCINESanofi Pasteur Inc.9/15/20096/30/2010 10/15/201949281-0650-50 True 10/15/2019126 Novel influenza-H1N1-09, preservative-freePMC
49281-0650-70 INFLUENZA A (H1N1) 2009 MONOVALENT VACCINESanofi Pasteur Inc.9/15/20096/30/2010 10/15/201949281-0650-70 True 10/15/2019126 Novel influenza-H1N1-09, preservative-freePMC
49281-0650-90 INFLUENZA A (H1N1) 2009 MONOVALENT VACCINESanofi Pasteur Inc.9/15/20096/30/2010 10/15/201949281-0650-90 True 10/15/2019126 Novel influenza-H1N1-09, preservative-freePMC
49281-0703-55 FLUZONE INTRADERMALSanofi Pasteur Inc.7/1/20116/30/2012 1/29/201849281-0703-55 True 00349281703553 2/27/2018144 influenza, seasonal, intradermal, preservative freePMC
49281-0705-55 FLUZONESanofi Pasteur Inc.7/2/20126/30/2013 12/7/201749281-0705-55 True 00349281705557 7/5/2018144 influenza, seasonal, intradermal, preservative freePMC
49281-0707-55 FLUZONESanofi Pasteur Inc.6/28/20136/30/2014 12/7/201749281-0707-48 False 00349281707483 2/22/2018144 influenza, seasonal, intradermal, preservative freePMC
49281-0708-40 FLUZONE INTRADERMAL QUADRIVALENTSanofi Pasteur Inc.12/11/20146/30/2015 12/7/201749281-0708-48 False 7/5/2018166 influenza, intradermal, quadrivalent, preservative freePMC
49281-0709-55 FLUZONE IntradermalSanofi Pasteur Inc.6/27/20146/30/2015 7/12/201849281-0709-48 False 00349281709487 7/5/2018144 influenza, seasonal, intradermal, preservative freePMC
49281-0710-40 FLUZONE INTRADERMAL QUADRIVALENTSanofi Pasteur Inc.7/1/20166/30/2017 7/11/201849281-0710-48 False 5/30/2018166 influenza, intradermal, quadrivalent, preservative freePMC
49281-0712-40 FLUZONE INTRADERMAL QUADRIVALENTSanofi Pasteur Inc.7/1/20176/30/2018 7/13/201849281-0712-48 False 00349281712487 7/9/2018166 influenza, intradermal, quadrivalent, preservative freePMC
49281-0718-10 Flublok QuadrivalentSanofi Pasteur Inc.6/29/20186/30/2019 7/16/201949281-0718-88 False 00349281718885 7/16/2019185 Influenza, recombinant, quadrivalent, PFPMC
49281-0719-10 Flublok QuadrivalentSanofi Pasteur Inc.7/1/20196/30/2020 7/18/202449281-0719-88 False 00349281719882 7/18/2024185 Influenza, recombinant, quadrivalent, PFPMC
49281-0720-10 Flublok Quadrivalent Northern HemisphereSanofi Pasteur Inc.7/1/20206/30/2021 7/18/202449281-0720-88 False 7/18/2024185 Influenza, recombinant, quadrivalent, PFPMC
49281-0721-10 Flublok Quadrivalent Northern HemisphereSanofi Pasteur Inc.7/2/20216/30/202200349281721106 7/18/202449281-0721-88 False 00349281721885 7/18/2024185 Influenza, recombinant, quadrivalent, PFPMC
49281-0722-10 Flublok Quadrivalent Northern HemisphereSanofi Pasteur Inc.7/1/20226/30/202300349281722103 7/18/202449281-0722-88 False 00349281722882 7/18/2024185 Influenza, recombinant, quadrivalent, PFPMC
49281-0723-10 Flublok Quadrivalent Northern HemisphereSanofi Pasteur Inc.6/30/20236/30/2024 7/18/202449281-0723-88 False 00349281723889 9/19/2024185 Influenza, recombinant, quadrivalent, PFPMC
49281-0724-10 FLUBLOK TRIVALENT NORTHERN HEMISPHERESanofi Pasteur Inc.7/1/202400349281724107 9/17/202449281-0724-88 False 00349281724886 9/17/2024155 Influenza, recombinant, trivalent, PFPMC
49281-0790-20 Typhim ViSanofi Pasteur Inc.11/28/199400349281790201 2/2/202349281-0790-38 False 00349281790386 2/2/2023101 typhoid, ViCPsPMC
49281-0790-51 Typhim ViSanofi Pasteur Inc.11/28/199400349281790515 2/2/202349281-0790-88 False 00349281790881 2/2/2023101 typhoid, ViCPsPMC
49281-0800-83 TETANUS TOXOID ADSORBEDSanofi Pasteur Inc.9/23/20055/5/2017 5/30/201849281-0800-83 True 5/30/201835 tetanus toxoid, adsorbedPMC
49281-0820-10 TETANUS TOXOID ADSORBEDSanofi Pasteur Inc.9/23/20055/5/2017 5/30/201849281-0820-10 True 5/30/201835 tetanus toxoid, adsorbedPMC
49281-0860-10 IPOLSanofi Pasteur Inc.12/21/199000349281860102 11/8/202149281-0860-78 False 00349281860782 2/1/202310 IPVPMC
49281-0860-10 IPOLSanofi Pasteur Inc.12/21/199000349281860102 11/8/202149281-0860-88 False 00349281860881 6/8/201810 IPVPMC
49281-0860-55 IPOLSanofi Pasteur Inc.12/21/19906/16/201100349281860553 11/8/202149281-0860-78 False 00349281860782 2/1/202310 IPVPMC
49281-0913-01 STAMARILSanofi Pasteur Inc.9/27/201600349281913013 10/26/202349281-0913-01 True 00349281913013 9/27/2024183 Yellow fever vaccine live - altPMC
49281-0915-01 YF-VAXSanofi Pasteur Inc.5/22/195300349281915017 2/2/202349281-0915-58 False 00349281915581 2/2/202337 yellow fever livePMC
49281-0915-05 YF-VAXSanofi Pasteur Inc.5/22/195300349281915055 2/2/202349281-0915-68 False 00349281915680 2/2/202337 yellow fever livePMC
49281-0933-50 FLUZONE High-Dose Quadrivalent Southern HemisphereSanofi Pasteur Inc.3/26/2024 10/16/202449281-0933-88 False 10/16/2024231 influenza, Southern Hemisphere, high-dose, quadrivalentPMC
50090-1502-00 HAVRIXA-S Medication Solutions8/1/2021 3/13/202450090-1502-09 False 2/3/202352 Hep A, adultSKB
50090-1693-09 IPOLA-S Medication Solutions8/17/2018 2/8/202450090-1693-00 False 2/2/202310 IPVPMC
50090-2062-00 TENIVACA-S Medication Solutions6/30/2023 7/11/202350090-2062-01 False 7/11/2023113 Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbedPMC
50090-2883-00 INFANRIXA-S Medication Solutions9/21/20181/1/2020 1/10/202350090-2883-09 False 1/13/202320 DTaPSKB
50090-3096-00 RabAvertA-S Medication Solutions8/17/20181/1/2020 1/10/202358160-0966-01 False 3/13/2024176 Rabies - IM fibroblast cultureSKB
50090-3469-00 HEPLISAV-BA-S Medication Solutions1/1/20181/1/2020 1/21/202050090-3469-09 False 1/21/2020189 HepB-CpGDVX
50090-3781-00 HAVRIXA-S Medication Solutions7/1/2024 7/12/202450090-3781-01 False 7/12/202483 Hep A, ped/adol, 2 doseSKB
50090-4958-01 GARDASIL 9A-S Medication Solutions5/22/2023 6/6/202350090-4958-00 False 5/25/2023165 HPV9MSD
50090-5147-00 ShingrixA-S Medication Solutions10/1/20201/6/2023 1/13/202358160-0828-01 False 10358160828017 1/17/2024187 zoster recombinantSKB
50090-6026-00 PREVNAR 20A-S Medication Solutions8/10/2021 3/1/202450090-6026-01 False 3/1/2024216 Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PFPFR
50090-6180-00 MENQUADFIA-S Medication Solutions5/3/2023 5/10/202350090-6180-01 False 2/15/2024203 meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)PMC
50090-7036-00 PNEUMOVAX 23A-S Medication Solutions3/11/2024 3/12/202450090-7036-01 False 3/12/202433 pneumococcal polysaccharide PPV23MSD
50632-0001-02 JYNNEOSBavarian Nordic A/S3/17/202100350632001020 9/26/202450632-0001-01 False 2/1/2023206 Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injectionBN
50632-0001-03 JYNNEOSBavarian Nordic A/S3/17/202100350632001037 9/26/202450632-0001-01 False 2/1/2023206 Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injectionBN
50632-0010-01 RabAvertBavarian Nordic A/S5/24/2021 2/21/202350632-0013-01 False 2/21/2023176 Rabies - IM fibroblast cultureBN
50632-0015-02 VaxchoraBavarian Nordic A/S6/1/202400350632015027 9/26/202450632-0015-02 True 6/14/2024174 cholera, live attenuatedBN
50632-0016-02 VivotifBavarian Nordic A/S7/1/2024 7/12/202450632-0016-04 False 7/12/202425 typhoid, oralBN
51285-0138-50 Adenovirus Type 4 and Type 7 Vaccine, LiveTeva Women's Health, Inc.5/31/2011 7/12/201851285-0175-02 False 1/27/2014143 Adenovirus types 4 and 7BRR
51285-0138-50 Adenovirus Type 4 and Type 7 Vaccine, LiveTeva Women's Health, Inc.5/31/2011 7/12/201851285-0175-02 False 1/27/2014143 Adenovirus types 4 and 7TVA
51285-0138-50 Adenovirus Type 4 and Type 7 Vaccine, LiveTeva Women's Health, Inc.5/31/2011 7/12/201851285-0174-02 False 1/27/2014143 Adenovirus types 4 and 7BRR
51285-0138-50 Adenovirus Type 4 and Type 7 Vaccine, LiveTeva Women's Health, Inc.5/31/2011 7/12/201851285-0174-02 False 1/27/2014143 Adenovirus types 4 and 7TVA
54868-0734-00 ENGERIX-BPhysicians Total Care, Inc.8/5/20026/30/2012 4/6/201854868-0734-00 True 4/6/201843 Hep B, adultSKB
54868-0980-00 M-M-R IIPhysicians Total Care, Inc.8/7/19966/30/2012 1/29/201854868-0980-00 True 1/29/201803 MMRMSD
54868-2219-00 RECOMBIVAX HBPhysicians Total Care, Inc.7/23/19866/30/2012 7/13/201854868-2219-00 True 4/6/201843 Hep B, adultMSD
54868-2219-01 RECOMBIVAX HBPhysicians Total Care, Inc.7/23/19866/30/2012 7/13/201854868-2219-01 True 4/6/201843 Hep B, adultMSD
54868-3339-01 PNEUMOVAX 23PHYSICIANS TOTAL CARE, INC9/20/19946/30/2009 7/13/201854868-3339-09 False 2/22/201833 pneumococcal polysaccharide PPV23MSD
54868-4320-00 PNEUMOVAX 23PHYSICIANS TOTAL CARE, INC2/20/20066/30/2011 7/13/201854868-4320-09 False 1/27/201433 pneumococcal polysaccharide PPV23MSD
54868-6177-00 FLUZONEPHYSICIANS TOTAL CARE, INC9/16/20106/30/2011 4/6/201854868-6177-00 True 4/6/2018141 Influenza, split virus, trivalent, preservativePMC
54868-6180-00 FLUZONEPHYSICIANS TOTAL CARE, INC9/21/20106/30/2011 4/6/201854868-6180-00 True 4/6/2018140 Influenza, split virus, trivalent, PFPMC
55045-3841-01 HAVRIXDispensing Solutions, Inc.4/13/200710/4/2019 10/15/201955045-3841-01 True 2/5/202152 Hep A, adultSKB
58160-0726-15 HiberixGlaxoSmithKline Biologicals SA12/20/202300358160726156 9/19/202458160-0816-03 False 1/25/202448 Hib (PRP-T)SKB
58160-0740-21 RotarixGlaxoSmithKline Biologicals SA2/1/202300358160740213 4/24/202358160-0740-02 False 10358160740029 4/24/2023119 rotavirus, monovalentSKB
58160-0801-11 MenhibrixGlaxoSmithKline Biologicals SA9/3/20139/17/201700358160801112 5/30/201858160-0809-01 False 00358160809019 5/30/2018148 Meningococcal C/Y-HIB PRPSKB
58160-0806-05 HIBERIXGlaxoSmithKline Biologicals SA8/24/200912/15/2011 6/8/201858160-0806-01 False 00358160806018 6/8/201848 Hib (PRP-T)SKB
58160-0808-15 Influenza A (H5N1) Monovalent Vaccine, AdjuvantedGlaxoSmithKline1/18/2018 3/27/202358160-0802-02 False 3/23/2023160 Influenza A monovalent (H5N1), ADJUVANTED-2013SKB
58160-0808-15 Influenza A (H5N1) Monovalent Vaccine, AdjuvantedGlaxoSmithKline1/18/2018 3/27/202358160-0804-01 False 3/27/2023160 Influenza A monovalent (H5N1), ADJUVANTED-2013SKB
58160-0809-05 MENHIBRIXGlaxoSmithKline Biologicals SA9/3/20139/17/2017 5/30/201858160-0809-01 False 00358160809019 5/30/2018148 Meningococcal C/Y-HIB PRPSKB
58160-0810-11 INFANRIXGlaxoSmithKline Biologicals SA7/24/200912/14/202200358160810114 12/16/202258160-0810-01 False 10358160810012 12/16/202220 DTaPSKB
58160-0810-52 INFANRIXGlaxoSmithKline Biologicals SA7/24/200900358160810527 1/31/202258160-0810-43 False 10358160810432 2/1/202320 DTaPSKB
58160-0811-51 PEDIARIXGlaxoSmithKline Biologicals SA7/24/20092/24/2011 6/8/201858160-0811-41 False 6/8/2018110 DTaP-Hep B-IPVSKB
58160-0811-52 PEDIARIXGlaxoSmithKline Biologicals SA7/24/200900358160811524 1/31/202258160-0811-43 False 10358160811439 2/1/2023110 DTaP-Hep B-IPVSKB
58160-0812-11 KINRIXGlaxoSmithKline Biologicals SA7/9/20086/10/202200358160812118 6/15/202258160-0812-01 False 10358160812016 6/14/2022130 DTaP-IPVSKB
58160-0812-52 KINRIXGlaxoSmithKline Biologicals SA7/9/200800358160812521 1/31/202258160-0812-43 False 10358160812436 2/1/2023130 DTaP-IPVSKB
58160-0815-11 TWINRIXGlaxoSmithKline Biologicals SA6/7/20071/18/201800358160815119 5/30/201858160-0815-01 False 00358160815010 6/8/2018104 Hep A-Hep BSKB
58160-0815-34 TWINRIXGlaxoSmithKline Biologicals SA6/7/20071/18/201800358160815348 5/30/201858160-0815-05 False 00358160815058 5/30/2018104 Hep A-Hep BSKB
58160-0815-46 TWINRIXGlaxoSmithKline Biologicals SA6/7/20072/3/2011 6/8/201858160-0815-41 False 3/23/2023104 Hep A-Hep BSKB
58160-0815-48 TWINRIXGlaxoSmithKline Biologicals SA6/7/20074/27/2011 6/8/201858160-0815-43 False 10358160815437 2/13/2024104 Hep A-Hep BSKB
58160-0815-52 TWINRIXGlaxoSmithKline Biologicals SA6/7/200700358160815522 2/13/202458160-0815-43 False 10358160815437 2/13/2024104 Hep A-Hep BSKB
58160-0816-05 HiberixGlaxoSmithKline Biologicals SA12/21/201500358160816055 7/6/201858160-0816-01 False 10358160816014 2/1/202348 Hib (PRP-T)SKB
58160-0818-11 HiberixGlaxoSmithKline Biologicals SA12/21/201500358160818110 7/6/201858160-0816-05 False 10358160816052 5/6/201948 Hib (PRP-T)SKB
58160-0819-12 ShingrixGlaxoSmithKline Biologicals SA10/20/201700358160819124 10/24/202358160-0828-01 False 10358160828017 1/17/2024187 zoster recombinantSKB
58160-0820-11 ENGERIX-BGlaxoSmithKline Biologicals SA4/25/20078/30/201900358160820113 9/4/201958160-0820-01 False 10358160820011 9/4/201908 Hep B, adolescent or pediatricSKB
58160-0820-52 ENGERIX-BGlaxoSmithKline Biologicals SA4/25/200700358160820526 12/7/201758160-0820-43 False 10358160820431 2/1/202308 Hep B, adolescent or pediatricSKB
58160-0821-11 ENGERIX-BGlaxoSmithKline Biologicals SA3/28/200700358160821110 12/7/201758160-0821-01 False 10358160821018 2/1/202344 Hep B, high-dosage, dialysis or ICSKB
58160-0821-11 ENGERIX-BGlaxoSmithKline Biologicals SA3/28/200700358160821110 12/7/201758160-0821-01 False 10358160821018 2/1/202343 Hep B, adultSKB
58160-0821-34 ENGERIX-BGlaxoSmithKline Biologicals SA3/28/200700358160821349 12/7/201758160-0821-05 False 10358160821056 2/1/202344 Hep B, high-dosage, dialysis or ICSKB
58160-0821-34 ENGERIX-BGlaxoSmithKline Biologicals SA3/28/200700358160821349 12/7/201758160-0821-05 False 10358160821056 2/1/202343 Hep B, adultSKB
58160-0821-52 ENGERIX-BGlaxoSmithKline Biologicals SA3/28/200700358160821523 12/7/201758160-0821-43 False 10358160821438 2/1/202344 Hep B, high-dosage, dialysis or ICSKB
58160-0821-52 ENGERIX-BGlaxoSmithKline Biologicals SA3/28/200700358160821523 12/7/201758160-0821-43 False 10358160821438 2/1/202343 Hep B, adultSKB
58160-0823-11 ShingrixGlaxoSmithKline Biologicals SA10/20/201700358160823114 10/8/201958160-0828-03 False 10358160828031 2/21/2023187 zoster recombinantSKB
58160-0824-15 PriorixGlaxoSmithKline Biologicals SA6/3/202200358160824159 10/17/202258160-0831-03 False 10358160831031 10/17/202203 MMRSKB
58160-0825-11 HAVRIXGlaxoSmithKline Biologicals SA2/16/20072/11/202100358160825118 4/5/202158160-0825-01 False 10358160825016 3/23/202183 Hep A, ped/adol, 2 doseSKB
58160-0825-52 HAVRIXGlaxoSmithKline Biologicals SA2/16/200700358160825521 12/7/201758160-0825-43 False 10358160825436 2/1/202383 Hep A, ped/adol, 2 doseSKB
58160-0826-11 HAVRIXGlaxoSmithKline Biologicals SA4/13/20072/11/202100358160826115 4/5/202158160-0826-01 False 10358160826013 3/23/202152 Hep A, adultSKB
58160-0826-34 HAVRIXGlaxoSmithKline Biologicals SA4/13/20073/3/202000358160826344 3/11/202058160-0826-05 False 10358160826051 3/11/202052 Hep A, adultSKB
58160-0826-52 HAVRIXGlaxoSmithKline Biologicals SA4/13/200700358160826528 12/7/201758160-0826-43 False 10358160826433 2/1/202352 Hep A, adultSKB
58160-0827-30 MenveoGlaxoSmithKline Biologicals SA12/9/202200358160827303 4/24/202358160-0827-03 False 10358160827034 5/12/2023136 Meningococcal MCV4OSKB
58160-0830-34 CERVARIXGlaxoSmithKline Biologicals SA10/16/200911/29/201600358160830341 5/30/201858160-0830-05 False 5/30/2018118 HPV, bivalentSKB
58160-0830-52 CERVARIXGlaxoSmithKline Biologicals SA10/16/200911/29/201600358160830525 5/30/201858160-0830-43 False 00358160830433 5/30/2018118 HPV, bivalentSKB
58160-0842-11 BOOSTRIXGlaxoSmithKline Biologicals SA7/24/200900358160842115 1/31/202258160-0842-01 False 10358160842013 2/1/2023115 TdapSKB
58160-0842-34 BOOSTRIXGlaxoSmithKline Biologicals SA7/24/200910/26/202000358160842344 1/12/202158160-0842-05 False 10358160842051 1/19/2023115 TdapSKB
58160-0842-51 BOOSTRIXGlaxoSmithKline Biologicals SA7/24/20096/15/201100358160842511 6/8/201858160-0842-41 False 6/8/2018115 TdapSKB
58160-0842-52 BOOSTRIXGlaxoSmithKline Biologicals SA7/24/200900358160842528 1/31/202258160-0842-43 False 10358160842433 2/1/2023115 TdapSKB
58160-0848-11 ArexvyGlaxoSmithKline Biologicals SA5/3/202300358160848117 6/4/202458160-0723-03 False 10358160723039 6/4/2024303 RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PFSKB
58160-0854-52 ROTARIXGlaxoSmithKline Biologicals SA1/13/201100358160854521 1/2/202458160-0851-01 False 10358160851015 1/2/2024119 rotavirus, monovalentSKB
58160-0855-19 AS03GlaxoSmithKline Biologicals SA11/10/20201/8/202400358160855191 3/12/202458160-0855-01 False 10358160855013 2/21/2024801 AS03 AdjuvantSKB
58160-0879-52 FLUARIXGlaxoSmithKline Biologicals SA7/20/20126/30/2013 12/7/201758160-0879-41 False 11/20/2017140 Influenza, split virus, trivalent, PFSKB
58160-0880-52 FLUARIXGlaxoSmithKline Biologicals SA7/1/20136/30/2014 12/7/201758160-0880-41 False 11/20/2017140 Influenza, split virus, trivalent, PFSKB
58160-0881-52 FLUARIXGlaxoSmithKline Biologicals SA6/27/20146/30/201500358160881527 5/30/201858160-0881-41 False 00358160881411 5/30/2018140 Influenza, split virus, trivalent, PFSKB
58160-0883-52 FLUARIXGlaxoSmithKline Biologicals SA8/3/20158/4/2015 5/30/201858160-0883-41 False 00358160883415 5/30/2018140 Influenza, split virus, trivalent, PFSKB
58160-0884-52 FLUARIXGlaxoSmithKline Biologicals SA7/1/2024 7/18/202458160-0884-41 False 7/23/2024140 Influenza, split virus, trivalent, PFSKB
58160-0885-52 FLUARIX QUADRIVALENTGlaxoSmithKline Biologicals SA7/2/20206/30/2021 7/18/202458160-0885-41 False 7/18/2024150 Influenza, split virus, quadrivalent, PFSKB
58160-0887-52 FLUARIX QUADRIVALENTGlaxoSmithKline Biologicals SA7/2/20216/30/202200358160887529 7/18/202458160-0887-41 False 10358160887410 7/18/2024150 Influenza, split virus, quadrivalent, PFSKB
58160-0890-52 FLUARIX QUADRIVALENTGlaxoSmithKline Biologicals SA7/1/20226/30/202300358160890529 7/18/202458160-0890-41 False 10358160890410 7/18/2024150 Influenza, split virus, quadrivalent, PFSKB
58160-0896-52 FLUARIX QUADRIVALENTGlaxoSmithKline Biologicals SA7/2/20196/30/2020 7/18/202458160-0896-41 False 7/18/2024150 Influenza, split virus, quadrivalent, PFSKB
58160-0898-52 FLUARIX QUADRIVALENTGlaxoSmithKline Biologicals SA6/29/20186/30/201900358160898525 7/16/201958160-0898-41 False 10358160898416 7/16/2019150 Influenza, split virus, quadrivalent, PFSKB
58160-0900-52 FLUARIX QUADRIVALENTGlaxoSmithKline Biologicals SA7/1/20136/30/2014 12/7/201758160-0900-41 False 11/20/2017150 Influenza, split virus, quadrivalent, PFSKB
58160-0901-52 FLUARIX QUADRIVALENTGlaxoSmithKline Biologicals SA7/1/20146/30/201500358160901522 5/30/201858160-0901-41 False 00358160901416 5/30/2018150 Influenza, split virus, quadrivalent, PFSKB
58160-0903-52 FLUARIX QUADRIVALENTGlaxoSmithKline Biologicals SA7/1/20156/30/2016 5/30/201858160-0903-41 False 00358160903410 5/30/2018150 Influenza, split virus, quadrivalent, PFSKB
58160-0905-52 FLUARIX QUADRIVALENTGlaxoSmithKline Biologicals SA7/1/20166/30/2017 7/11/201858160-0905-41 False 7/5/2018150 Influenza, split virus, quadrivalent, PFSKB
58160-0907-52 FLUARIX QUADRIVALENTGlaxoSmithKline Biologicals SA7/7/20176/30/2018 7/9/201858160-0907-41 False 7/9/2018150 Influenza, split virus, quadrivalent, PFSKB
58160-0909-52 FLUARIX QUADRIVALENTGlaxoSmithKline Biologicals SA6/30/20236/30/2024 7/18/202458160-0909-41 False 7/23/2024150 Influenza, split virus, quadrivalent, PFSKB
58160-0955-09 MenveoGlaxoSmithKline Biologicals SA3/1/201700358160955099 12/16/202258160-0958-01 False 10358160958011 12/16/2022136 Meningococcal MCV4OSKB
58160-0955-09 MenveoGlaxoSmithKline Biologicals SA3/1/201700358160955099 12/16/202258160-0959-01 False 10358160959018 12/16/2022136 Meningococcal MCV4OSKB
58160-0964-12 RabAvertGlaxoSmithKline Biologicals SA12/19/20161/31/202400358160964121 3/13/202458160-0966-01 False 3/13/2024176 Rabies - IM fibroblast cultureSKB
58160-0964-12 RabAvertGlaxoSmithKline Biologicals SA12/19/20161/31/202400358160964121 3/13/202458160-0966-12 False 7/13/2018176 Rabies - IM fibroblast cultureSKB
58160-0976-06 BexseroGlaxoSmithKline Biologicals SA12/1/201612/31/202100358160976063 1/10/202258160-0976-02 False 10358160976022 2/1/2023163 meningococcal B, OMVSKB
58160-0976-20 BexseroGlaxoSmithKline Biologicals SA12/1/201600358160976209 1/31/202258160-0976-02 False 10358160976022 2/1/2023163 meningococcal B, OMVSKB
59267-0078-04 Pfizer-BioNTech Covid-19 VaccinePfizer Manufacturing Belgium NV6/17/20224/18/2023 5/3/202359267-0078-01 False 1/17/2024219 COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrosePFR
59267-0304-02 Pfizer-BioNTech Covid-19 Vaccine, BivalentPfizer Manufacturing Belgium NV9/1/20229/11/2023 10/26/202359267-0304-01 False 10/26/2023300 COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dosePFR
59267-0565-02 Pfizer-BioNTech Covid-19 Vaccine, BivalentPfizer Manufacturing Belgium NV10/12/20229/11/2023 10/26/202359267-0565-01 False 10/26/2023301 COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dosePFR
59267-0609-02 Pfizer-BioNTech Covid-19 Vaccine, BivalentPfizer Manufacturing Belgium NV12/9/20229/11/2023 10/26/202359267-0609-01 False 10/26/2023302 COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dosePFR
59267-1000-02 Pfizer-BioNTech Covid-19 VaccinePfizer Manufacturing Belgium NV12/12/20204/18/2023 5/3/202359267-1000-01 False 5/3/2023208 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dosePFR
59267-1000-03 Pfizer-BioNTech Covid-19 VaccinePfizer Manufacturing Belgium NV12/12/20204/18/2023 5/3/202359267-1000-01 False 5/3/2023208 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dosePFR
59267-1025-02 Pfizer-BioNTech Covid-19 VaccinePfizer Manufacturing Belgium NV10/1/202111/1/2021 11/9/202159267-1025-01 False 5/3/2023217 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrosePFR
59267-1025-03 Pfizer-BioNTech Covid-19 VaccinePfizer Manufacturing Belgium NV10/1/20214/18/2023 5/3/202359267-1025-01 False 5/3/2023217 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrosePFR
59267-1025-04 Pfizer-BioNTech Covid-19 VaccinePfizer Manufacturing Belgium NV10/1/20214/18/2023 5/3/202359267-1025-01 False 5/3/2023217 COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrosePFR
59267-1055-02 Pfizer-BioNTech Covid-19 VaccinePfizer Manufacturing Belgium NV10/1/202111/1/2021 11/9/202159267-1055-01 False 5/3/2023218 COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrosePFR
59267-1055-04 Pfizer-BioNTech Covid-19 VaccinePfizer Manufacturing Belgium NV10/1/20214/18/2023 5/3/202359267-1055-01 False 5/3/2023218 COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrosePFR
59267-1404-02 Pfizer-BioNTech Covid-19 Vaccine, BivalentPfizer Manufacturing Belgium NV9/1/20229/11/2023 10/26/202359267-1404-01 False 10/26/2023300 COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dosePFR
59267-4315-02 Pfizer-BioNTech Covid-19 VaccinePfizer Manufacturing Belgium NV9/11/20237/31/202400359267431523 9/19/202459267-4315-01 False 10359267431513 9/19/2024308 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mLPFR
59267-4331-02 Pfizer-BioNTech Covid-19 VaccinePfizer Manufacturing Belgium NV9/11/20238/31/202400359267433121 9/19/202459267-4331-01 False 10359267433111 9/19/2024310 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mLPFR
59267-4426-02 Pfizer-BioNTech Covid-19 VaccinePfizer Manufacturing Belgium NV8/22/2024 8/30/202459267-4426-01 False 8/30/2024308 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mLPFR
59267-4438-02 Pfizer-BioNTech Covid-19 VaccinePfizer Manufacturing Belgium NV8/22/2024 8/30/202459267-4438-01 False 8/30/2024310 COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mLPFR
59676-0580-15 Janssen COVID-19 VaccineJanssen Products, LP2/1/20216/20/2023 7/11/202359676-0580-05 False 7/10/2023212 COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mLJSN
62195-0051-01 IxiaroVetter Pharma Fertigung GmbH & Co. KG11/23/2020 12/29/202062195-0051-01 True 6/15/2018134 Japanese Encephalitis IMVAL
62195-0051-10 IxiaroVetter Pharma Fertigung GmbH & Co. KG3/30/200911/23/2020 12/29/202062195-0051-01 False 6/15/2018134 Japanese Encephalitis IMVAL
62577-0613-01 FlucelvaxNovartis Vaccines and Diagnostics, Inc.7/1/20146/30/2015 5/30/201862577-0613-11 False 5/30/2018153 Influenza, MDCK, trivalent, PFNOV
62577-0614-01 FlucelvaxNovartis Vaccines and Diagnostics, Inc.7/1/20146/30/2016 7/6/201862577-0614-11 False 7/5/2018153 Influenza, MDCK, trivalent, PFNOV
63361-0243-10 VAXELISMSP Vaccine Company4/10/202000363361243104 9/19/202463361-0243-58 False 00363361243586 9/19/2024146 DTaP,IPV,Hib,HepBMSP
63361-0243-15 VAXELISMSP Vaccine Company10/1/202000363361243159 9/19/202463361-0243-88 False 00363361243883 9/19/2024146 DTaP,IPV,Hib,HepBMSP
63361-0245-10 VAXELISMCM Vaccine Co.12/21/20184/10/2020 4/21/202063361-0245-58 False 9/19/2024146 DTaP,IPV,Hib,HepBPMC
63851-0501-01 RabAvertNovartis Vaccines and Diagnostics GmbH10/20/19971/19/2017 6/8/201863851-0511-11 False 00363851511119 4/15/2020176 Rabies - IM fibroblast cultureNOV
63851-0501-02 RabAvertGSK Vaccines GmbH7/8/20143/31/202000363851501028 4/16/202063851-0511-11 False 00363851511119 4/15/2020176 Rabies - IM fibroblast cultureNOV
63851-0612-01 FlucelvaxNovartis Vaccines and Diagnostics GmbH8/30/20136/30/2014 5/30/201863851-0612-11 False 5/30/2018153 Influenza, MDCK, trivalent, PFNOV
63851-0613-01 FLUCELVAXNovartis Vaccines and Diagnostics GmbH7/1/20146/30/2015 5/30/201863851-0613-11 False 5/30/2018153 Influenza, MDCK, trivalent, PFNOV
64678-0211-01 BioThraxEmergent BioDefense Operations Lansing, LLC11/4/1970 12/7/201764678-0211-05 False 2/1/202324 Anthrax, pre-exposure prophylaxis, post-exposure prophylaxisMIP
66019-0107-01 FLUMISTMedImmune, LLC7/17/20094/19/2010 7/13/201866019-0107-01 True 2/13/2018111 Influenza, live, trivalent, intranasalMED
66019-0108-10 FLUMISTMedImmune, LLC7/22/20106/30/2011 7/13/201866019-0108-01 False 1/29/2018111 Influenza, live, trivalent, intranasalMED
66019-0109-10 FLUMISTMedImmune, LLC6/30/20117/19/2012 7/13/201866019-0109-01 False 1/29/2018111 Influenza, live, trivalent, intranasalMED
66019-0110-10 FluMistMedImmune, LLC8/1/20127/18/2013 7/13/201866019-0110-01 False 11/20/2017111 Influenza, live, trivalent, intranasalMED
66019-0200-10 Influenza A H1N1 IntranasalMedImmune, LLC10/1/20094/13/2010 7/13/201866019-0200-01 False 1/29/2018125 Novel Influenza-H1N1-09, nasalMED
66019-0300-10 FluMist QuadrivalentMedImmune, LLC7/15/20136/30/2014 7/13/201866019-0300-01 False 5/30/2018149 Influenza, live, quadrivalent, intranasalMED
66019-0301-10 FluMist QuadrivalentMedImmune, LLC7/1/20146/30/2015 7/12/201866019-0301-01 False 5/30/2018149 Influenza, live, quadrivalent, intranasalMED
66019-0302-10 FluMist QuadrivalentMedImmune, LLC7/15/20136/30/2016 7/13/201866019-0302-01 False 5/30/2018149 Influenza, live, quadrivalent, intranasalMED
66019-0303-10 FluMist QuadrivalentMedImmune, LLC7/25/20166/30/2017 7/12/201866019-0303-01 False 5/30/2018149 Influenza, live, quadrivalent, intranasalMED
66019-0304-10 FluMist QuadrivalentMedImmune, LLC8/25/20176/30/2018 8/20/201866019-0304-01 False 8/20/2018149 Influenza, live, quadrivalent, intranasalMED
66019-0305-10 FluMist QuadrivalentMedImmune, LLC8/10/20184/30/2019 5/21/201966019-0305-01 False 5/21/2019149 Influenza, live, quadrivalent, intranasalMED
66019-0306-10 FluMist QuadrivalentMedImmune, LLC9/5/20193/6/2020 7/18/202466019-0306-01 False 7/18/2024149 Influenza, live, quadrivalent, intranasalMED
66019-0307-10 FluMist QuadrivalentMedImmune, LLC8/10/20204/1/2021 7/18/202466019-0307-01 False 7/18/2024149 Influenza, live, quadrivalent, intranasalMED
66019-0308-10 FluMist QuadrivalentMedImmune, LLC8/2/20213/15/202200366019308101 7/18/202466019-0308-01 False 7/18/2024149 Influenza, live, quadrivalent, intranasalMED
66019-0309-10 FluMist QuadrivalentMedImmune, LLC8/8/20223/15/2023 7/18/202466019-0309-01 False 7/18/2024149 Influenza, live, quadrivalent, intranasalMED
66019-0310-10 FluMist QuadrivalentMedImmune, LLC8/14/20238/5/2024 9/17/202466019-0310-01 False 9/17/2024149 Influenza, live, quadrivalent, intranasalMED
66019-0311-10 FluMistMedImmune, LLC8/6/2024 9/3/202466019-0311-00 False 8/28/2024111 Influenza, live, trivalent, intranasalMED
66521-0000-01 FLUADNovartis Vaccines and Diagnostics Limited11/24/20156/30/2016 8/13/201866521-0000-11 False 7/9/2018168 Influenza, adjuvanted, trivalent, PFNOV
66521-0112-02 FluvirinNovartis Vaccines and Diagnostics Ltd8/12/19986/30/2010 5/30/201866521-0112-02 True 7/5/2018140 Influenza, split virus, trivalent, PFNOV
66521-0112-10 FluvirinNovartis Vaccines and Diagnostics Ltd8/12/19986/30/2010 5/30/201866521-0112-10 True 7/5/2018141 Influenza, split virus, trivalent, preservativeNOV
66521-0113-02 FLUVIRINNovartis Vaccines and Diagnostics Limited8/12/19886/30/2011 5/30/201866521-0113-02 True 7/5/2018140 Influenza, split virus, trivalent, PFNOV
66521-0113-10 FLUVIRINNovartis Vaccines and Diagnostics Limited8/12/19886/30/2011 5/30/201866521-0113-10 True 7/5/2018141 Influenza, split virus, trivalent, preservativeNOV
66521-0114-02 FLUVIRINNovartis Vaccines and Diagnostics Limited7/1/20116/30/2012 5/30/201866521-0114-02 True 4/23/2020140 Influenza, split virus, trivalent, PFNOV
66521-0114-10 FLUVIRINNovartis Vaccines and Diagnostics Limited7/1/20116/30/2012 5/30/201866521-0114-10 True 5/30/2018141 Influenza, split virus, trivalent, preservativeNOV
66521-0115-02 FLUVIRINNovartis Vaccines and Diagnostics Limited7/20/20126/30/2013 5/30/201866521-0115-02 True 00366521115020 7/5/2018140 Influenza, split virus, trivalent, PFNOV
66521-0115-10 FLUVIRINNovartis Vaccines and Diagnostics Limited7/20/20126/30/2013 5/30/201866521-0115-10 True 7/5/2018141 Influenza, split virus, trivalent, preservativeNOV
66521-0116-02 FluvirinNovartis Vaccines and Diagnostics Limited7/30/20136/30/2014 3/5/201866521-0116-12 False 11/20/2017140 Influenza, split virus, trivalent, PFNOV
66521-0116-10 FluvirinNovartis Vaccines and Diagnostics Limited7/30/20136/30/2014 12/7/201766521-0116-11 False 11/20/2017141 Influenza, split virus, trivalent, preservativeNOV
66521-0117-02 FluvirinNovartis Vaccines and Diagnostics Ltd7/1/20146/30/2015 7/6/201866521-0117-12 False 7/5/2018140 Influenza, split virus, trivalent, PFNOV
66521-0117-10 FluvirinNovartis Vaccines and Diagnostics Ltd7/1/20146/30/2015 7/6/201866521-0117-11 False 00366521117116 7/5/2018141 Influenza, split virus, trivalent, preservativeNOV
66521-0118-02 FluvirinNovartis Vaccines and Diagnostics Limited7/1/20156/30/2016 7/11/201866521-0118-12 False 7/9/2018140 Influenza, split virus, trivalent, PFNOV
66521-0118-10 FluvirinNovartis Vaccines and Diagnostics Limited7/1/20156/30/2016 7/11/201866521-0118-11 False 7/9/2018141 Influenza, split virus, trivalent, preservativeNOV
66521-0200-02 Influenza A (H1N1) 2009 Monovalent VaccineNovartis Vaccines and Diagnostics Ltd9/15/20096/30/2010 10/15/201966521-0200-02 True 10/15/2019127 Novel influenza-H1N1-09NOV
66521-0200-10 Influenza A (H1N1) 2009 Monovalent VaccineNovartis Vaccines and Diagnostics Ltd9/15/20096/30/2010 10/15/201966521-0200-10 True 10/15/2019126 Novel influenza-H1N1-09, preservative-freeNOV
69401-0000-02 VivotifEmergent Travel Health Inc.3/16/199200369401000027 10/9/202469401-0000-01 False 2/1/202325 typhoid, oralPAX
70460-0001-01 VaxchoraPaxvax, Inc.10/3/20168/1/2021 8/16/202170460-0002-02 False 8/16/2021174 cholera, live attenuatedPAX
70460-0004-01 VaxchoraEmergent Travel Health Inc.9/15/201900370460004017 9/26/202470460-0002-02 False 8/16/2021174 cholera, live attenuatedPAX
70461-0001-01 FLUADSeqirus, Inc.7/1/20166/30/2017 7/12/201870461-0001-11 False 7/5/2018168 Influenza, adjuvanted, trivalent, PFSEQ
70461-0002-01 FLUADSeqirus Inc.7/1/20176/30/2018 7/9/201870461-0002-11 False 7/9/2018168 Influenza, adjuvanted, trivalent, PFSEQ
70461-0018-03 FLUADSeqirus, Inc.7/13/20187/31/2019 8/22/201970461-0018-04 False 8/15/2019168 Influenza, adjuvanted, trivalent, PFSEQ
70461-0019-03 FLUADSeqirus, Inc.8/1/20196/30/202000370461019034 7/18/202470461-0019-04 False 00370461019041 7/18/2024168 Influenza, adjuvanted, trivalent, PFSEQ
70461-0020-03 FLUADSeqirus, Inc.7/1/20207/31/2021 7/18/202470461-0020-04 False 7/18/2024168 Influenza, adjuvanted, trivalent, PFSEQ
70461-0024-03 FLUADSeqirus, Inc.7/1/202400370461024038 9/27/202470461-0024-04 False 00370461024045 9/27/2024168 Influenza, adjuvanted, trivalent, PFSEQ
70461-0119-02 FluvirinSeqirus, Inc.7/1/20166/30/2017 7/12/201870461-0119-12 False 5/30/2018140 Influenza, split virus, trivalent, PFSEQ
70461-0119-10 FluvirinSeqirus, Inc.7/1/20166/30/2017 7/12/201870461-0119-11 False 5/30/2018141 Influenza, split virus, trivalent, preservativeSEQ
70461-0120-02 FluvirinSeqirus Inc.7/1/20176/30/2018 7/9/201870461-0120-12 False 7/9/2018140 Influenza, split virus, trivalent, PFSEQ
70461-0120-03 FLUAD QUADRIVALENTSeqirus, Inc.7/1/20206/30/2021 7/18/202470461-0120-04 False 7/18/2024205 Influenza, adjuvanted, quadrivalent, PFSEQ
70461-0120-10 FluvirinSeqirus Inc.7/1/20176/30/2018 7/9/201870461-0120-11 False 7/9/2018141 Influenza, split virus, trivalent, preservativeSEQ
70461-0121-03 FLUAD QUADRIVALENTSeqirus, Inc.7/1/20216/30/2022 7/18/202470461-0121-04 False 7/18/2024205 Influenza, adjuvanted, quadrivalent, PFSEQ
70461-0122-03 FLUAD QUADRIVALENTSeqirus, Inc.7/1/20227/31/202300370461122031 7/18/202470461-0122-04 False 00370461122048 7/18/2024205 Influenza, adjuvanted, quadrivalent, PFSEQ
70461-0123-03 FLUAD QUADRIVALENTSeqirus, Inc.7/1/20236/30/202400370461123038 8/6/202470461-0123-04 False 00370461123045 8/6/2024205 Influenza, adjuvanted, quadrivalent, PFSEQ
70461-0200-01 FLUCELVAX QUADRIVALENTSeqirus, Inc.7/1/20166/30/2017 7/13/201870461-0200-11 False 7/5/2018171 Influenza, MDCK, quadrivalent, PFSEQ
70461-0201-01 FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE)Seqirus, Inc.7/1/20176/30/2018 7/9/201870461-0201-11 False 7/9/2018171 Influenza, MDCK, quadrivalent, PFSEQ
70461-0301-10 FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL)Seqirus, Inc.7/1/20176/30/2018 7/9/201870461-0301-12 False 7/9/2018186 Influenza, MDCK, quadrivalent, preservativeSEQ
70461-0318-03 FLUCELVAX QUADRIVALENT (PREFILLED SYRINGE)Seqirus, Inc.7/1/20187/31/2019 1/23/202070461-0318-04 False 8/22/2019171 Influenza, MDCK, quadrivalent, PFSEQ
70461-0319-03 FLUCELVAX QUADRIVALENTSeqirus, Inc.7/30/20197/31/202000370461319035 7/18/202470461-0319-04 False 00370461319042 7/18/2024171 Influenza, MDCK, quadrivalent, PFSEQ
70461-0320-03 FLUCELVAX QUADRIVALENTSeqirus Inc.7/2/20207/1/2021 7/18/202470461-0320-04 False 7/18/2024171 Influenza, MDCK, quadrivalent, PFSEQ
70461-0321-03 FLUCELVAX QUADRIVALENTSeqirus Inc.7/1/20216/30/2022 7/18/202470461-0321-04 False 7/18/2024171 Influenza, MDCK, quadrivalent, PFSEQ
70461-0322-03 Flucelvax QuadrivalentSeqirus Inc.7/1/20226/30/202300370461322035 7/18/202470461-0322-04 False 00370461322042 7/18/2024171 Influenza, MDCK, quadrivalent, PFSEQ
70461-0323-03 Flucelvax QuadrivalentSeqirus Inc.7/1/20236/30/2024 8/6/202470461-0323-04 False 00370461323049 8/6/2024171 Influenza, MDCK, quadrivalent, PFSEQ
70461-0418-10 FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL)Seqirus, Inc.7/1/20187/31/2019 8/22/201970461-0418-11 False 8/22/2019186 Influenza, MDCK, quadrivalent, preservativeSEQ
70461-0419-10 FLUCELVAX QUADRIVALENTSeqirus, Inc.7/30/20197/31/202000370461419100 7/18/202470461-0419-11 False 00370461419117 7/18/2024186 Influenza, MDCK, quadrivalent, preservativeSEQ
70461-0420-10 FLUCELVAX QUADRIVALENTSeqirus Inc.7/2/20207/1/2021 7/18/202470461-0420-11 False 7/18/2024186 Influenza, MDCK, quadrivalent, preservativeSEQ
70461-0421-10 FLUCELVAX QUADRIVALENTSeqirus Inc.7/2/20216/30/2022 7/18/202470461-0421-11 False 7/18/2024186 Influenza, MDCK, quadrivalent, preservativeSEQ
70461-0422-10 Flucelvax QuadrivalentSeqirus Inc.7/1/20226/30/202300370461422100 7/18/202470461-0422-11 False 00370461422117 7/18/2024186 Influenza, MDCK, quadrivalent, preservativeSEQ
70461-0423-10 Flucelvax QuadrivalentSeqirus Inc.7/1/20236/30/202400370461423107 8/6/202470461-0423-11 False 00370461423114 8/6/2024186 Influenza, MDCK, quadrivalent, preservativeSEQ
70461-0554-10 FlucelvaxSeqirus Inc.7/1/202400370461554108 9/27/202470461-0554-11 False 00370461554115 9/27/2024320 Influenza, MDCK, trivalent, preservativeSEQ
70461-0654-03 FlucelvaxSeqirus Inc.7/1/202400370461654037 9/27/202470461-0654-04 False 00370461654044 9/27/2024153 Influenza, MDCK, trivalent, PFSEQ
71665-0001-02 CYFENDUSEmergent Product Development Gaithersburg Inc.9/19/2023 6/11/202471665-0001-01 False 1/25/2024318 Anthrax, post-exposure prophylaxisMIP
71665-0330-02 ACAM2000Emergent Product Development Gaithersburg Inc.8/31/2007 6/15/202271665-0330-01 False 2/1/202375 vaccinia (smallpox)MIP
75052-0001-10 PREHEVBRIOVBI Vaccines (Delaware) Inc.12/1/202111/15/2024 12/6/202475052-0001-01 False 12/6/2024220 HepB recombinant, 3-antigen, Al(OH)3VBI
76420-0482-01 Medical Provider Single Use EZ Flu Shot 2013-2014MedChem Manufacturing Inc. dba Enovachem5/30/20136/30/2014 7/13/201876420-0482-01 True 5/30/2018150 Influenza, split virus, quadrivalent, PFPMC
76420-0483-01 Medical Provider Single Use EZ Flu Shot 2013-2014MedChem Manufacturing Inc. dba Enovachem5/30/20136/30/2014 7/13/201876420-0483-01 True 5/30/2018150 Influenza, split virus, quadrivalent, PFPMC
80631-0100-10 NOVAVAX COVID-19 Vaccine, AdjuvantedNovavax, Inc.3/1/202210/3/2023 7/29/202480631-0100-01 False 7/29/2024211 COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mLNVX
80631-0102-10 NOVAVAX COVID-19 Vaccine, AdjuvantedNovavax, Inc.2/1/202310/3/2023 7/29/202480631-0102-01 False 7/29/2024211 COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mLNVX
80631-0105-02 NOVAVAX COVID-19 Vaccine, AdjuvantedNovavax, Inc.9/1/20237/29/2024 8/6/202480631-0105-01 False 8/6/2024313 COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mLNVX
80631-0107-10 NOVAVAX COVID-19 VACCINE, ADJUVANTEDNovavax, Inc.8/30/2024 9/9/202480631-0107-01 False 9/9/2024313 COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mLNVX
80777-0100-99 SpikevaxModerna US, Inc.6/1/20224/18/2023 10/24/202380777-0100-11 False 10/24/2023207 COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL doseMOD
80777-0102-93 SpikevaxModerna US, Inc.9/11/20238/21/202400380777102931 9/24/202480777-0102-01 False 00380777102016 9/24/2024312 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mLMOD
80777-0102-95 SpikevaxModerna US, Inc.9/11/20238/21/202400380777102955 9/24/202480777-0102-04 False 00380777102047 9/24/2024312 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mLMOD
80777-0102-96 SpikevaxModerna US, Inc.9/11/20238/21/202400380777102962 9/24/202480777-0102-01 False 00380777102016 9/24/2024312 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mLMOD
80777-0110-93 SpikevaxModerna US, Inc.8/22/202400380777110936 9/26/202480777-0110-01 False 00380777110011 9/26/2024312 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mLMOD
80777-0110-96 SpikevaxModerna US, Inc.8/22/202400380777110967 9/26/202480777-0110-01 False 00380777110011 9/26/2024312 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mLMOD
80777-0273-98 Moderna COVID-19 VaccineModerna US, Inc.4/1/20214/18/2023 5/30/202380777-0273-15 False 5/30/2023207 COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL doseMOD
80777-0273-99 Moderna COVID-19 VaccineModerna US, Inc.12/18/20204/18/2023 5/30/202380777-0273-10 False 5/30/2023207 COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL doseMOD
80777-0275-99 Moderna COVID-19 VaccineModerna US, Inc.3/29/20224/18/2023 5/30/202380777-0275-05 False 5/30/2023221 COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL doseMOD
80777-0277-99 Moderna COVID-19 VaccineModerna US, Inc.6/1/20226/1/2022 5/30/202380777-0277-05 False 5/30/2023227 COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL doseMOD
80777-0279-99 Moderna COVID-19 VaccineModerna US, Inc.6/1/20224/18/2023 5/30/202380777-0279-05 False 5/30/2023228 COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL doseMOD
80777-0282-99 Moderna COVID-19 Vaccine, BivalentModerna US, Inc.7/28/20229/11/2023 10/26/202380777-0282-05 False 10/26/2023229 COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL doseMOD
80777-0283-99 Moderna COVID-19 Vaccine, BivalentModerna US, Inc.9/23/20229/11/2023 10/26/202380777-0283-02 False 10/26/2023230 COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mLMOD
80777-0287-92 Moderna COVID-19 VaccineModerna US, Inc.9/11/20238/21/2024 8/30/202480777-0287-07 False 8/30/2024311 COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mLMOD
80777-0291-80 Moderna COVID-19 VaccineModerna US, Inc.8/22/202400380777291802 9/26/202480777-0291-09 False 00380777291093 9/26/2024311 COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mLMOD
80777-0291-81 Moderna COVID-19 VaccineModerna US, Inc.8/22/2024 8/30/202480777-0291-09 False 00380777291093 9/26/2024311 COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mLMOD
80777-0345-89 mRESVIAModerna US, INC.11/5/2024 11/21/202480777-0345-01 False 6/11/2024326 RSV, mRNA, injectable, PFMOD
80777-0345-90 mRESVIAModerna US, INC.5/31/2024 6/11/202480777-0345-01 False 6/11/2024326 RSV, mRNA, injectable, PFMOD
80777-0345-96 mRESVIAModerna US, INC.5/31/2024 6/11/202480777-0345-01 False 6/11/2024326 RSV, mRNA, injectable, PFMOD

 Top of Page

Column Definitions

Sale NDC11: NDC11 for the unit of sale

Sale Proprietary Name: Proprietary name of the unit of sale

Sale Labeler: Name of the labeler

Sale Start Date: Date product began to be marketed

Sale End Date: Date product was no longer marketed

Sale GTIN: GTIN barcode for unit of sale

Sale Last update: Date the unit of sale record was last updated

Use NDC11: NDC11 for unit of use

No Use NDC: Indicator if unit of sale has NDC. If TRUE, the unit of use NDC is set to match unit of sale NDC.

Use GTIN: GTIN barcode for unit of use

Use Last update: Date the unit of use record was last updated

CVX: CVX code for product

CVX Name: Vaccine name from CVX table


Page last reviewed: December 18, 2024
Content source: National Center for Immunization and Respiratory Diseases